Title: Full Text of HB1697
Official Title: 
Number of Sections: 1
Source: versions - Enrolled
Media Type: text/html

================================================================================

Section 1:
Full Text of HB1697 ILGA.GOV HB1697 - 104th General Assembly HB1697 EnrolledLRB104 03541 RTM 13564 b1    AN ACT concerning State government. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 1. This Act may be referred to as the Prescription 5Drug Affordability Act. 6    Section 5. The State Employees Group Insurance Act of 1971 7is amended by changing Section 6.11 as follows: 8    (5 ILCS 375/6.11)9    Sec. 6.11. Required health benefits; Illinois Insurance 10Code requirements. The program of health benefits shall 11provide the post-mastectomy care benefits required to be 12covered by a policy of accident and health insurance under 13Section 356t of the Illinois Insurance Code. The program of 14health benefits shall provide the coverage required under 15Sections 356g, 356g.5, 356g.5-1, 356m, 356q, 356u, 356u.10, 16356w, 356x, 356z.2, 356z.4, 356z.4a, 356z.5, 356z.6, 356z.8, 17356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 18356z.17, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 19356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 20356z.51, 356z.53, 356z.54, 356z.55, 356z.56, 356z.57, 356z.59, 21356z.60, 356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 22356z.70, and 356z.71, 356z.74, 356z.76, and 356z.77 of the   HB1697 Enrolled- 2 -LRB104 03541 RTM 13564 b1Illinois Insurance Code. The program of health benefits must 2comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 3370c.1 and Article XXXIIB of the Illinois Insurance Code. The 4program of health benefits shall provide the coverage required 5under Section 356m of the Illinois Insurance Code and, for the 6employees of the State Employee Group Insurance Program only, 7the coverage as also provided in Section 6.11B of this Act. The 8Department of Insurance shall enforce the requirements of this 9Section with respect to Sections 370c and 370c.1 and Article 10XXXIIB of the Illinois Insurance Code; all other requirements 11of this Section shall be enforced by the Department of Central 12Management Services.13    Rulemaking authority to implement Public Act 95-1045, if 14any, is conditioned on the rules being adopted in accordance 15with all provisions of the Illinois Administrative Procedure 16Act and all rules and procedures of the Joint Committee on 17Administrative Rules; any purported rule not so adopted, for 18whatever reason, is unauthorized. 19(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 20102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 211-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-768, 22eff. 1-1-24; 102-804, eff. 1-1-23; 102-813, eff. 5-13-22; 23102-816, eff. 1-1-23; 102-860, eff. 1-1-23; 102-1093, eff. 241-1-23; 102-1117, eff. 1-13-23; 103-8, eff. 1-1-24; 103-84, 25eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, eff. 1-1-24; 26103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 103-551, eff.   HB1697 Enrolled- 3 -LRB104 03541 RTM 13564 b18-11-23; 103-605, eff. 7-1-24; 103-718, eff. 7-19-24; 103-751, 2eff. 8-2-24; 103-870, eff. 1-1-25; 103-914, eff. 1-1-25; 3103-918, eff. 1-1-25; 103-951, eff. 1-1-25; 103-1024, eff. 41-1-25; revised 11-26-24.) 5    Section 10. The Department of Commerce and Economic 6Opportunity Law of the Civil Administrative Code of Illinois 7is amended by changing Section 605-60 as follows: 8    (20 ILCS 605/605-60)9    Sec. 605-60. DCEO Projects Fund. 10    (a) The DCEO Projects Fund is created as a trust fund in 11the State treasury. The Department is authorized to accept and 12deposit into the Fund moneys received from any gifts, grants, 13transfers, or other sources, public or private, unless deposit 14into a different fund is otherwise mandated. 15    (b) Subject to appropriation, the Department shall use 16moneys in the Fund to make grants or loans to and enter into 17contracts with units of local government, local and regional 18economic development corporations, retail associations, and 19not-for-profit organizations for municipal development 20projects, for the specific purposes established by the terms 21and conditions of the gift, grant, or award, and for related 22administrative expenses. As used in this Section, the term 23"municipal development projects" includes, but is not limited 24to, grants for reducing food insecurity in urban and rural   HB1697 Enrolled- 4 -LRB104 03541 RTM 13564 b1areas.2    (c) In this subsection, "rural tract" and "urban tract" 3have the meanings given to those terms in Section 5 of the 4Grocery Initiative Act.5    Subject to appropriation, the Department shall use moneys 6deposited into the Fund pursuant to Section 513b2 of the 7Illinois Insurance Code to make a grant to a statewide retail 8association representing pharmacies to promote access to 9pharmacies and pharmacist services. Grant funds under this 10subsection shall be made available to the following 11beneficiaries: 12        (1) critical access care pharmacies as defined in 13    Section 5-5.12b of the Illinois Public Aid Code;14        (2) retail pharmacies with a physical location in 15    Illinois owned by a person or entity with an ownership or 16    control interest in fewer than 10 pharmacies;17        (3) retail pharmacies with a physical location in a 18    county in Illinois with fewer than 50,000 residents;19        (4) retail pharmacies with a physical location in a 20    county in Illinois with 50,000 or more residents and in an 21    area within Illinois that is designated by the United 22    States Department of Health and Human Services as either: 23    (A) a Medically Underserved Area, including Governor's 24    Exceptions; or (B) a Medically Underserved Population, 25    including Governor's Exceptions;26        (5) pharmacies whose claims constitute 65% or greater   HB1697 Enrolled- 5 -LRB104 03541 RTM 13564 b1    for Medicaid services and at least 80% of their total 2    claims are for pharmacy services administered in Illinois;3        (6) a pharmacy located in an Illinois census tract 4    that meets both of the following poverty and population 5    density and pharmacy accessibility standards:6            (A) the census tract has either: (i) 20% or more of 7        its population living below the poverty guidelines 8        updated periodically in the Federal Register by the 9        U.S. Department of Health and Human Services under the 10        authority of 42 U.S.C. 9902(2); or (ii) a median 11        household income of less than 80% of the median income 12        of the nearest metropolitan area; and13            (B) the census tract has at least 33% of its 14        population living one mile or more from the pharmacy 15        for urban tracts or more than 10 miles from the 16        pharmacy for rural tracts.17    At least annually, the Department shall file with the 18Governor and the General Assembly a report that includes: 19        (1) the number of beneficiaries who applied for 20    funding; 21        (2) the number of beneficiaries who received funding; 22    and 23        (3) the pharmacies that were awarded funding, 24    including the location, the amount of funding, and the 25    subsection category or categories under which the pharmacy 26    qualified.  HB1697 Enrolled- 6 -LRB104 03541 RTM 13564 b1(Source: P.A. 103-588, eff. 6-5-24.) 2    Section 12. The State Finance Act is amended by adding 3Section 5.1030 as follows: 4    (30 ILCS 105/5.1030 new)5    Sec. 5.1030. The Prescription Drug Affordability Fund. 6    Section 15. The School Code is amended by changing Section 710-22.3f as follows: 8    (105 ILCS 5/10-22.3f)9    Sec. 10-22.3f. Required health benefits. Insurance 10protection and benefits for employees shall provide the 11post-mastectomy care benefits required to be covered by a 12policy of accident and health insurance under Section 356t and 13the coverage required under Sections 356g, 356g.5, 356g.5-1, 14356m, 356q, 356u, 356u.10, 356w, 356x, 356z.4, 356z.4a, 15356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 16356z.15, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 17356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 18356z.51, 356z.53, 356z.54, 356z.56, 356z.57, 356z.59, 356z.60, 19356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 356z.70, and 20356z.71, 356z.74, and 356z.77 of the Illinois Insurance Code. 21Insurance policies shall comply with Section 356z.19 of the 22Illinois Insurance Code. The coverage shall comply with   HB1697 Enrolled- 7 -LRB104 03541 RTM 13564 b1Sections 155.22a, 355b, and 370c and Article XXXIIB of the 2Illinois Insurance Code. The Department of Insurance shall 3enforce the requirements of this Section. 4    Rulemaking authority to implement Public Act 95-1045, if 5any, is conditioned on the rules being adopted in accordance 6with all provisions of the Illinois Administrative Procedure 7Act and all rules and procedures of the Joint Committee on 8Administrative Rules; any purported rule not so adopted, for 9whatever reason, is unauthorized. 10(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 11102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 121-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-804, 13eff. 1-1-23; 102-813, eff. 5-13-22; 102-816, eff. 1-1-23; 14102-860, eff. 1-1-23; 102-1093, eff. 1-1-23; 102-1117, eff. 151-13-23; 103-84, eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, 16eff. 1-1-24; 103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 17103-551, eff. 8-11-23; 103-605, eff. 7-1-24; 103-718, eff. 187-19-24; 103-751, eff. 8-2-24; 103-914, eff. 1-1-25; 103-918, 19eff. 1-1-25; 103-1024, eff. 1-1-25; revised 11-26-24.) 20    Section 20. The Illinois Insurance Code is amended by 21changing Sections 513b1, 513b2, and 513b3 and by adding 22Section 513b1.1 as follows: 23    (215 ILCS 5/513b1)24    Sec. 513b1. Pharmacy benefit manager contracts.  HB1697 Enrolled- 8 -LRB104 03541 RTM 13564 b1    (a) As used in this Section: 2    "340B drug discount program" means the program established 3under Section 340B of the federal Public Health Service Act, 442 U.S.C. 256b. 5    "340B entity" means a covered entity as defined in 42 6U.S.C. 256b(a)(4) authorized to participate in the 340B drug 7discount program. 8    "340B pharmacy" means any pharmacy used to dispense 340B 9drugs for a covered entity, whether entity-owned or external.10    "Affiliate" means a person or entity that directly or 11indirectly through one or more intermediaries controls or is 12controlled by, or is under common control with, the person or 13entity specified. The location of a person or entity's 14domicile, whether in Illinois or a foreign or alien 15jurisdiction, does not affect the person or entity's status as 16an affiliate.17    "Biological product" has the meaning ascribed to that term 18in Section 19.5 of the Pharmacy Practice Act.19    "Brand name drug" means a drug that has been approved 20under 42 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 21marketed, sold, or distributed under a proprietary, 22trademark-protected name.23    "Complex or chronic medical condition" means a physical, 24behavioral, or developmental condition that has no known cure, 25is progressive, or can be debilitating or fatal if unmanaged 26or untreated.  HB1697 Enrolled- 9 -LRB104 03541 RTM 13564 b1    "Covered individual" means a member, participant, 2enrollee, contract holder, policyholder, or beneficiary of a 3health benefit plan who is provided a drug benefit by the 4health benefit plan.5    "Critical access pharmacy" means a critical access care 6pharmacy as defined in Section 5-5.12b of the Illinois Public 7Aid Code.8    "Drugs" has the meaning ascribed to that term in Section 3 9of the Pharmacy Practice Act and includes biological products.10    "Generic drug" means a drug that has been approved under 1142 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 12marketed, sold, or distributed directly or indirectly to the 13retail class of trade with labeling, packaging (other than 14repackaging as the listed drug in blister packs, unit doses, 15or similar packaging for use in institutions), product code, 16labeler code, trade name, or trademark that differs from that 17of the brand name drug.18    "Health benefit plan" means a policy, contract, 19certificate, or agreement entered into, offered, or issued by 20an insurer to provide, deliver, arrange for, pay for, or 21reimburse any of the costs of physical, mental, or behavioral 22health care services. Notwithstanding Sections 122-1 through 23122-4 of this Code, "health benefit plan" includes self-funded 24employee welfare benefit plans. Notwithstanding Sections 122-1 25through 122-4 of this Code, "health benefit plan" includes 26self-funded employee welfare benefit plans except for   HB1697 Enrolled- 10 -LRB104 03541 RTM 13564 b1self-funded multiemployer plans that are not nonfederal 2government plans.3    "Maximum allowable cost" means the maximum amount that a 4pharmacy benefit manager will reimburse a pharmacy for the 5cost of a drug. 6    "Maximum allowable cost list" means a list of drugs for 7which a maximum allowable cost has been established by a 8pharmacy benefit manager. 9    "Pharmacy benefit manager" means a person, business, or 10entity, including a wholly or partially owned or controlled 11subsidiary of a pharmacy benefit manager, that provides claims 12processing services or other prescription drug or device 13services, or both, for health benefit plans.14    "Pharmacy" has the meaning given to that term in Section 3 15of the Pharmacy Practice Act. 16    "Pharmacy services" means the provision of any services 17listed within the definition of "practice of pharmacy" under 18subsection (d) of Section 3 of the Pharmacy Practice Act.19    "Rare medical condition" means a physical, behavioral, or 20developmental condition that affects fewer than 200,000 21individuals in the United States or approximately 1 in 1,500 22individuals worldwide.23    "Rebate" means a discount or pricing concession based on 24drug utilization or administration that is paid by the 25manufacturer to a pharmacy benefit manager or its client. 26    "Rebate aggregator" means a person or entity, including   HB1697 Enrolled- 11 -LRB104 03541 RTM 13564 b1group purchasing organizations, that negotiate rebates or 2other fees with drug manufacturers on behalf or for the 3benefit of a pharmacy benefit manager or its client and may 4also be involved in contracts that entitle the rebate 5aggregator or its client to receive rebates or other fees from 6drug manufacturers based on drug utilization or 7administration. 8    "Retail price" means the price an individual without 9prescription drug coverage would pay at a retail pharmacy, not 10including a pharmacist dispensing fee. 11    "Specialty drug" means a drug that:12        (1) is prescribed for a person with a complex or 13    chronic medical condition or a rare medical condition;14        (2) has limited or exclusive distribution; and15        (3) requires both:16            (A) specialized product handling by the dispensing 17        pharmacy or administration by the dispensing pharmacy; 18        and19            (B) specialized clinical care, including frequent 20        dosing adjustments, intensive clinical monitoring, or 21        expanded services for patients, including intensive 22        patient counseling, education, or ongoing clinical 23        support beyond traditional dispensing activities, such 24        as individualized disease and therapy management to 25        support improved health outcomes.26    "Spread pricing" means the model of drug pricing in which   HB1697 Enrolled- 12 -LRB104 03541 RTM 13564 b1the pharmacy benefit manager charges a health benefit plan a 2contracted price for drugs, and the contracted price for the 3drugs differs from the amount the pharmacy benefit manager 4directly or indirectly pays the pharmacist or pharmacy for the 5drugs, pharmacist services, or drug and dispensing fees.6    "Steer" includes, but is not limited to:7        (1) requiring a covered individual to only use a 8    pharmacy, including a mail-order or specialty pharmacy, in 9    which the pharmacy benefit manager or its affiliate 10    maintains an ownership interest or control;11        (2) offering or implementing a plan design that 12    encourages a covered individual to only use a pharmacy in 13    which the pharmacy benefit manager or an affiliate 14    maintains an ownership interest or control, if the plan 15    design increases costs for the covered individual. This 16    includes a plan design that requires a covered individual 17    to pay higher costs or an increased share of costs for a 18    drug or drug-related service if the covered individual 19    uses a pharmacy that is not owned or controlled by the 20    pharmacy benefit manager or its affiliate.21        (3) reimbursing a pharmacy or pharmacist for a drug 22    and pharmacist service in an amount less than the amount 23    that the pharmacy benefit manager reimburses itself or an 24    affiliate, including affiliated manufacturers or joint 25    ventures for providing the same drug or service. 26    "Third-party payer" means any entity that pays for   HB1697 Enrolled- 13 -LRB104 03541 RTM 13564 b1prescription drugs on behalf of a patient other than a health 2care provider or sponsor of a plan subject to regulation under 3Medicare Part D, 42 U.S.C. 1395w-101 et seq.4    (a-5) In this Article, references to an "insurer" or 5"health insurer" shall include commercial private health 6insurance issuers, managed care organizations, managed care 7community networks, and any other third-party payer that 8contracts with pharmacy benefit managers or with the 9Department of Healthcare and Family Services to provide 10benefits or services under the Medicaid program or to 11otherwise engage in the administration or payment of pharmacy 12benefits. However, the terms do not refer to the plan sponsor 13of a self-funded, single-employer employee welfare benefit 14plan or self-funded multiemployer plan subject to 29 U.S.C. 151144.16    (b) A contract between a health insurer and a pharmacy 17benefit manager must require that the pharmacy benefit 18manager: 19        (1) Update maximum allowable cost pricing information 20    at least every 7 calendar days. 21        (2) Maintain a process that will, in a timely manner, 22    eliminate drugs from maximum allowable cost lists or 23    modify drug prices to remain consistent with changes in 24    pricing data used in formulating maximum allowable cost 25    prices and product availability. 26        (3) Provide access to its maximum allowable cost list   HB1697 Enrolled- 14 -LRB104 03541 RTM 13564 b1    to each pharmacy or pharmacy services administrative 2    organization subject to the maximum allowable cost list. 3    Access may include a real-time pharmacy website portal to 4    be able to view the maximum allowable cost list. As used in 5    this Section, "pharmacy services administrative 6    organization" means an entity operating within the State 7    that contracts with independent pharmacies to conduct 8    business on their behalf with third-party payers. A 9    pharmacy services administrative organization may provide 10    administrative services to pharmacies and negotiate and 11    enter into contracts with third-party payers or pharmacy 12    benefit managers on behalf of pharmacies. 13        (4) Provide a process by which a contracted pharmacy 14    can appeal the provider's reimbursement for a drug subject 15    to maximum allowable cost pricing. The appeals process 16    must, at a minimum, include the following: 17            (A) A requirement that a contracted pharmacy has 18        14 calendar days after the applicable fill date to 19        appeal a maximum allowable cost if the reimbursement 20        for the drug is less than the net amount that the 21        network provider paid to the supplier of the drug. 22            (B) A requirement that a pharmacy benefit manager 23        must respond to a challenge within 14 calendar days of 24        the contracted pharmacy making the claim for which the 25        appeal has been submitted.26            (C) A telephone number and e-mail address or   HB1697 Enrolled- 15 -LRB104 03541 RTM 13564 b1        website to network providers, at which the provider 2        can contact the pharmacy benefit manager to process 3        and submit an appeal.4            (D) A requirement that, if an appeal is denied, 5        the pharmacy benefit manager must provide the reason 6        for the denial and the name and the national drug code 7        number from national or regional wholesalers.8            (E) A requirement that, if an appeal is sustained, 9        the pharmacy benefit manager must make an adjustment 10        in the drug price effective the date the challenge is 11        resolved and make the adjustment applicable to all 12        similarly situated network pharmacy providers, as 13        determined by the managed care organization or 14        pharmacy benefit manager. 15        (5) Allow a plan sponsor or insurer whose coverage is 16    administered by the contracting with a pharmacy benefit 17    manager an annual right to audit compliance with the terms 18    of the contract by the pharmacy benefit manager, 19    including, but not limited to, full disclosure of any and 20    all rebate amounts secured, whether product specific or 21    generalized rebates, that were provided to the pharmacy 22    benefit manager by a pharmaceutical manufacturer. The cost 23    of the audit shall be borne exclusively by the pharmacy 24    benefit manager. 25        (6) Allow a plan sponsor or insurer whose coverage is 26    administered by the contracting with a pharmacy benefit   HB1697 Enrolled- 16 -LRB104 03541 RTM 13564 b1    manager to request that the pharmacy benefit manager 2    disclose the actual amounts paid by the pharmacy benefit 3    manager to the pharmacy.4        (7) Provide notice to the plan sponsor or the insurer 5    party contracting with the pharmacy benefit manager of any 6    consideration that the pharmacy benefit manager receives 7    from the manufacturer for dispense as written 8    prescriptions once a generic or biologically similar 9    product becomes available. 10    (c) In order to place a particular prescription drug on a 11maximum allowable cost list, the pharmacy benefit manager 12must, at a minimum, ensure that: 13        (1) if the drug is a generically equivalent drug, it 14    is listed as therapeutically equivalent and 15    pharmaceutically equivalent "A" or "B" rated in the United 16    States Food and Drug Administration's most recent version 17    of the "Orange Book" or have an NR or NA rating by 18    Medi-Span, Gold Standard, or a similar rating by a 19    nationally recognized reference; 20        (2) the drug is available for purchase by each 21    pharmacy in the State from national or regional 22    wholesalers operating in Illinois; and 23        (3) the drug is not obsolete. 24    (d) A pharmacy benefit manager is prohibited from limiting 25a pharmacist's ability to disclose whether the cost-sharing 26obligation exceeds the retail price for a covered prescription   HB1697 Enrolled- 17 -LRB104 03541 RTM 13564 b1drug, and the availability of a more affordable alternative 2drug, if one is available in accordance with Section 42 of the 3Pharmacy Practice Act. 4    (e) A health insurer or pharmacy benefit manager shall not 5require a covered individual an insured to make a payment for a 6prescription drug at the point of sale in an amount that 7exceeds the lesser of: 8        (1) the applicable cost-sharing amount; or9        (2) the retail price of the drug in the absence of 10    prescription drug coverage;11        (3) the discounted price presented by the covered 12    individual through a no-cost drug program or drug 13    manufacturer voucher provided by or for the covered 14    individual at the point of sale; or15        (4) the discounted price presented by the covered 16    individual through a discounted health care services plan 17    provided by or for the covered individual at the point of 18    sale. 19    (f) Unless required by law, a contract between a pharmacy 20benefit manager or third-party payer and a 340B entity or 340B 21pharmacy shall not contain any provision that: 22        (1) distinguishes between drugs purchased through the 23    340B drug discount program and other drugs when 24    determining reimbursement or reimbursement methodologies, 25    or contains otherwise less favorable payment terms or 26    reimbursement methodologies for 340B entities or 340B   HB1697 Enrolled- 18 -LRB104 03541 RTM 13564 b1    pharmacies when compared to similarly situated non-340B 2    entities; 3        (2) imposes any fee, chargeback, or rate adjustment 4    that is not similarly imposed on similarly situated 5    pharmacies that are not 340B entities or 340B pharmacies; 6        (3) imposes any fee, chargeback, or rate adjustment 7    that exceeds the fee, chargeback, or rate adjustment that 8    is not similarly imposed on similarly situated pharmacies 9    that are not 340B entities or 340B pharmacies; 10        (4) prevents or interferes with an individual's choice 11    to receive a covered prescription drug from a 340B entity 12    or 340B pharmacy through any legally permissible means, 13    except that nothing in this paragraph shall prohibit the 14    establishment of differing copayments or other 15    cost-sharing amounts within the health benefit plan for 16    covered individuals persons who acquire covered 17    prescription drugs from a nonpreferred or nonparticipating 18    provider; 19        (5) excludes a 340B entity or 340B pharmacy from a 20    pharmacy network on any basis that includes consideration 21    of whether the 340B entity or 340B pharmacy participates 22    in the 340B drug discount program; 23        (6) prevents a 340B entity or 340B pharmacy from using 24    a drug purchased under the 340B drug discount program; or 25        (7) any other provision that discriminates against a 26    340B entity or 340B pharmacy by treating the 340B entity   HB1697 Enrolled- 19 -LRB104 03541 RTM 13564 b1    or 340B pharmacy differently than non-340B entities or 2    non-340B pharmacies for any reason relating to the 3    entity's participation in the 340B drug discount program. 4    As used in this subsection, "pharmacy benefit manager" and 5"third-party payer" do not include pharmacy benefit managers 6and third-party payers acting on behalf of a Medicaid program.7    (f-5) A pharmacy benefit manager or an affiliate acting on 8its behalf shall not conduct spread pricing.9    (f-10) A pharmacy benefit manager or an affiliate acting 10on its behalf shall not steer a covered individual. Existing 11agreements entered into before the effective date of this 12amendatory Act of the 104th General Assembly shall supersede 13this subsection until the termination of the current term of 14such agreement.15    (f-15) A pharmacy benefit manager or affiliated rebate 16aggregator must remit no less than 100% of any amounts paid by 17a pharmaceutical manufacturer, wholesaler, or other 18distributor of a drug, including, but not limited to, rebates, 19group purchasing fees, and other fees, to the health benefit 20plan sponsor, covered individual, or employer. Records of 21rebates and fees remitted from the pharmacy benefit manager or 22rebate aggregator must be disclosed to the Department annually 23in a format to be specified by the Department. The records 24received by the Department shall be considered confidential 25and privileged for all purposes, including for purposes of the 26Freedom of Information Act, shall not be subject to subpoena   HB1697 Enrolled- 20 -LRB104 03541 RTM 13564 b1from any private party, and shall not be admissible as 2evidence in a civil action.3    (f-20) A pharmacy benefit manager or an affiliate acting 4on its behalf is prohibited from limiting a covered 5individual's access to drugs from a pharmacy or pharmacist 6enrolled with the health benefit plan under the terms offered 7to all pharmacies in the plan coverage area by designating the 8covered drug as a specialty drug contrary to the definition in 9this Section.10    (f-25) The contract between the pharmacy benefit manager 11and the insurer or health benefit plan sponsor must allow and 12provide for the pharmacy benefit manager's compliance with an 13audit at least once per calendar year of the rebate and fee 14records remitted from a pharmacy benefit manager or its 15affiliated party to a health benefit plan. This audit may be 16incorporated into the audit under paragraph (5) of subsection 17(b) of this Section. Contracts with rebate aggregators, 18pharmacy services administrative organizations, pharmacies, or 19drug manufacturers must be available for audit by health 20benefit plan sponsors, insurers, or their designees at least 21once per plan year. Audits shall be performed by an auditor 22selected by the health benefit plan sponsor, insurer, or its 23designee. Health benefit plan sponsors and insurers shall give 24the pharmacy benefit manager a complete copy of the audit and 25the pharmacy benefit manager shall provide a complete copy of 26those findings to the Department within 60 days of initial   HB1697 Enrolled- 21 -LRB104 03541 RTM 13564 b1receipt. Rebate contracts with rebate aggregators, pharmacy 2services administrative organizations, pharmacies, or drug 3manufacturers shall be available for audit by health benefit 4plan sponsor, insurer, or designee. Nothing in this Section 5shall limit the Department's ability to access the books and 6records and any and all copies thereof of pharmacy benefit 7managers, their affiliates, or affiliated rebate aggregators. 8The records received by the Department shall be considered 9confidential and privileged for all purposes, including for 10purposes of the Freedom of Information Act, shall not be 11subject to subpoena from any private party, and shall not be 12admissible as evidence in a civil action. 13    (g) A violation of this Section by a pharmacy benefit 14manager constitutes an unfair or deceptive act or practice in 15the business of insurance under Section 424. 16    (h) A provision that violates subsection (f) in a contract 17between a pharmacy benefit manager or a third-party payer and 18a 340B entity that is entered into, amended, or renewed after 19July 1, 2022 shall be void and unenforceable. This subsection 20and subsection (f) do not apply to a contract directly between 21a 340B entity and the plan sponsor of a self-funded, 22single-employer or multiemployer employee welfare benefit plan 23subject to 29 U.S.C. 1144. 24    (i)(1) A pharmacy benefit manager may not retaliate 25against a pharmacist or pharmacy for disclosing information in 26a court, in an administrative hearing, before a legislative   HB1697 Enrolled- 22 -LRB104 03541 RTM 13564 b1commission or committee, or in any other proceeding, if the 2pharmacist or pharmacy has reasonable cause to believe that 3the disclosed information is evidence of a violation of a 4State or federal law, rule, or regulation.5    (2) A pharmacy benefit manager may not retaliate against a 6pharmacist or pharmacy for disclosing information to a 7government or law enforcement agency, if the pharmacist or 8pharmacy has reasonable cause to believe that the disclosed 9information is evidence of a violation of a State or federal 10law, rule, or regulation.11    (3) A pharmacist or pharmacy shall make commercially 12reasonable efforts to limit the disclosure of confidential and 13proprietary information.14    (4) Retaliatory actions against a pharmacy or pharmacist 15include cancellation of, restriction of, or refusal to renew 16or offer a contract to a pharmacy solely because the pharmacy 17or pharmacist has:18        (A) made disclosures of information that the 19    pharmacist or pharmacy has reasonable cause to believe is 20    evidence of a violation of a State or federal law, rule, or 21    regulation;22        (B) filed complaints with the plan or pharmacy benefit 23    manager; or24        (C) filed complaints against the plan or pharmacy 25    benefit manager with the Department.26    (j) This Section applies to contracts entered into or   HB1697 Enrolled- 23 -LRB104 03541 RTM 13564 b1renewed on or after July 1, 2022 and, unless provided 2otherwise in this Section or in the Illinois Public Aid Code, 3applies to pharmacy benefit managers that are contracted with 4a Medicaid managed care entity on or after January 1, 2026. 5    (k) This Section applies to any health benefit group or 6individual policy of accident and health insurance or managed 7care plan that provides coverage for prescription drugs and 8that is amended, delivered, issued, or renewed on or after 9July 1, 2020. The changes made to this Section by this 10amendatory Act of the 104th General Assembly shall apply with 11respect to any health benefit plan that provides coverage for 12drugs that is amended, delivered, issued, or renewed on or 13after January 1, 2026. 14    (l) A pharmacy benefit manager is responsible for 15compliance with all State requirements applicable to pharmacy 16benefit managers even if an action or responsibility of a 17pharmacy benefit manager is delegated to or completed by an 18affiliate. 19(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; 20103-453, eff. 8-4-23.) 21    (215 ILCS 5/513b1.1 new)22    Sec. 513b1.1. Pharmacy benefit manager reporting 23requirements.24    (a) A pharmacy benefit manager that provides services for 25a health benefit plan must submit an annual report no later   HB1697 Enrolled- 24 -LRB104 03541 RTM 13564 b1than September 1, to the Department, each health benefit plan 2sponsor, and each insurer that includes the following:3        (1) data on the health benefit plan including:4            (A) a list of drugs including corresponding 5        information on therapeutic class, brand name, generic 6        name, or specialty drug name;7            (B) number of covered individuals;8            (C) number of drug-related claims;9            (D) dosage units;10            (E) dispensing channel used;11            (F) average wholesale acquisition cost per drug; 12        and13            (G) total out-of-pocket spending by deidentified 14        covered individual per drug, per transaction;15        (2) amount received by the health benefit plan in 16    rebates, fees, or discounts related to drug utilization or 17    spending;18        (3) total gross spending on drugs by the health 19    benefit plan;20        (4) total net spending, gross spending less 21    administrative portion of the medical loss ratio, on drugs 22    by the health benefit plan;23        (5) the amount paid by the health benefit plan to the 24    pharmacy benefit manager for reimbursement cost of a drug 25    and service per transaction;26        (6) the amount a pharmacy benefit manager paid for   HB1697 Enrolled- 25 -LRB104 03541 RTM 13564 b1    pharmacists' services and drugs rendered related to the 2    health benefit plan per transaction, including, but not 3    limited to, any dispensing fee;4        (7) the specific rebate amount received by the 5    pharmacy benefit manager per transaction, the amount of 6    the rebates passed through to the health benefit plan per 7    transaction, and the amount of the rebates passed on to 8    covered individuals at the point of sale that reduced the 9    covered individuals' applicable deductible, copayment, 10    coinsurance, or other cost-sharing amount per transaction;11        (8) any information collected from drug manufacturers 12    pertaining to copayment assistance to the extent such 13    information is collected;14        (9) any compensation paid to brokers, consultants, 15    advisors, or any other individual or firm for referrals, 16    consideration, or retention by the health benefit plan;17        (10) explanation of benefit design parameters 18    encouraging or requiring covered individuals to use 19    affiliated pharmacies, percentage of drugs charged by 20    these pharmacies, and a list of drugs dispensed by 21    affiliated pharmacies with their associated costs; and22        (11) a complete copy of each unredacted contract the 23    pharmacy benefit manager has with the health benefit plan 24    sponsor or insurer.25    (b) Annual reports pursuant to subsection (a):26        (1) must be written in plain language to ensure ease   HB1697 Enrolled- 26 -LRB104 03541 RTM 13564 b1    of reading and accessibility;2        (2) must only contain summary health information to 3    ensure plan, coverage, or covered individual information 4    remains private and confidential;5        (3) upon request by a covered individual, must be 6    available in summary format and provide aggregated 7    information to help covered individuals understand their 8    health benefit plan's drug coverage; and9        (4) must be filed with the Department no later than 10    September 1 of each year via the Systems for Electronic 11    Rates & Forms Filing (SERFF). The filing shall include the 12    summary version of the report described in paragraph (3) 13    of this subsection, which shall be marked for public 14    access.15    The Department may share all reports with an established 16institution of higher education in this State for the creation 17of a pharmacist dispensing cost report to be produced 18annually. This annual pharmacist dispensing cost report shall 19provide a survey of the average cost of dispensing a 20prescription for pharmacists in Illinois. The institution of 21higher education shall have the ability to request additional 22information from pharmacists for its analysis. The institution 23of higher education shall issue the report to the General 24Assembly no later than December 31, 2026 and annually 25thereafter. 26    (c) A pharmacy benefit manager may petition the Department   HB1697 Enrolled- 27 -LRB104 03541 RTM 13564 b1for a filing submission extension. The Director may grant or 2deny the extension within 5 business days.3    (d) Failure by a pharmacy benefit manager to submit all 4required elements in an annual report to the Department may 5result in a fine levied by the Director not to exceed $10,000 6per day, per offense. Funds derived from fines levied shall be 7deposited into the Insurance Producer Administration Fund. 8Fine information shall be posted on the Department's website.9    (e) A pharmacy benefit manager found in violation of 10subsection (a) or paragraph (4) of subsection (b) may request 11a hearing from the Director within 10 days of receipt of the 12Director's order, or, if the violation is found in a market 13conduct examination, as provided in Section 132 of this Code.14    (f) Except for the summary version, the annual reports 15submitted by pharmacy benefit managers shall be considered 16confidential and privileged for all purposes, including for 17purposes of the Freedom of Information Act, shall not be 18subject to subpoena from any private party, and shall not be 19admissible as evidence in a civil action.20    (g) A copy of an adverse decision against a pharmacy 21benefit manager for failing to submit an annual report to the 22Department must be posted to the Department's website.23    (h) Nothing in this Section shall be construed as 24permitting a pharmacy benefit manager to avoid or otherwise 25fail to comply with the reporting requirements set forth in 26Section 5-36 of the Illinois Public Aid Code.   HB1697 Enrolled- 28 -LRB104 03541 RTM 13564 b1    (215 ILCS 5/513b2)2    Sec. 513b2. Licensure requirements.3    (a) Beginning on July 1, 2020, to conduct business in this 4State, a pharmacy benefit manager must register with the 5Director. To initially register or renew a registration, a 6pharmacy benefit manager shall submit: 7        (1) A nonrefundable fee not to exceed $500. 8        (2) A copy of the registrant's corporate charter, 9    articles of incorporation, or other charter document. 10        (3) A completed registration form adopted by the 11    Director containing: 12            (A) The name and address of the registrant. 13            (B) The name, address, and official position of 14        each officer and director of the registrant. 15    (b) The registrant shall report any change in information 16required under this Section to the Director in writing within 1760 days after the change occurs. 18    (c) Upon receipt of a completed registration form, the 19required documents, and the registration fee, the Director 20shall issue a registration certificate. The certificate may be 21in paper or electronic form, and shall clearly indicate the 22expiration date of the registration. Registration certificates 23are nontransferable. 24    (d) A registration certificate is valid for 2 years after 25its date of issue. The Director shall adopt by rule an initial   HB1697 Enrolled- 29 -LRB104 03541 RTM 13564 b1registration fee not to exceed $500 and a registration renewal 2fee not to exceed $500, both of which shall be nonrefundable. 3Total fees may not exceed the cost of administering this 4Section. 5    (e) The Department shall adopt any rules necessary to 6implement this Section. 7    (f) On or before August 1, 2025, the pharmacy benefit 8manager shall submit a report to the Department that lists the 9name of each health benefit plan it administers, provides the 10number of covered individuals for each health benefit plan as 11of the date of submission, and provides the total number of 12covered individuals across all health benefit plans the 13pharmacy benefit manager administers. On or before September 141, 2025, a registered pharmacy benefit manager, as a condition 15of its authority to transact business in this State, must 16submit to the Department an amount equal to $15 or an alternate 17amount as determined by the Director by rule per covered 18individual enrolled by the pharmacy benefit manager in this 19State, as detailed in the report submitted to the Department 20under this subsection, during the preceding calendar year. On 21or before September 1, 2026 and each September 1 thereafter, 22payments submitted under this subsection shall be based on the 23number of covered individuals reported to the Department in 24Section 513b1.1. 25    (g) All amounts collected under this Section shall be 26deposited into the Prescription Drug Affordability Fund, which   HB1697 Enrolled- 30 -LRB104 03541 RTM 13564 b1is hereby created as a special fund in the State treasury. Of 2the amounts collected under this Section each fiscal year, the 3Department shall transfer the first $25,000,000 into the DCEO 4Projects Fund for grants to pharmacies under Section 605-60 of 5the Department of Commerce and Economic Opportunity Law. 6(Source: P.A. 101-452, eff. 1-1-20.) 7    (215 ILCS 5/513b3)8    Sec. 513b3. Examination. 9    (a) The Director, or his or her designee, may examine a 10registered pharmacy benefit manager related to all of its 11lines of business, including government programs, under the 12Director's jurisdiction in accordance with Sections 132-132.7. 13If the Director or the examiners find that the pharmacy 14benefit manager has violated this Article or any other 15insurance-related or health benefits-related laws, rules, or 16regulations under the Director's jurisdiction because of the 17manner in which the pharmacy benefit manager has conducted 18business on behalf of a health insurer or plan sponsor, then, 19unless the health insurer or plan sponsor is included in the 20examination and has been afforded the same opportunity to 21request or participate in a hearing on the examination report, 22the examination report shall not allege a violation by the 23health insurer or plan sponsor and the Director's order based 24on the report shall not impose any requirements, prohibitions, 25or penalties on the health insurer or plan sponsor. Nothing in   HB1697 Enrolled- 31 -LRB104 03541 RTM 13564 b1this Section shall prevent the Director from using any 2information obtained during the examination of an 3administrator to examine, investigate, or take other 4appropriate regulatory or legal action with respect to a 5health insurer or plan sponsor.6    (b) The examination requirement for the pharmacy benefit 7manager to provide convenient and free access to all books and 8records under Sections 132 and 132.4 of this Code includes, at 9the Director's discretion, unredacted copies furnished 10electronically to the Director's market conduct surveillance 11personnel or examiners. Access must include information 12related to third-party entities affiliated or contracted with 13the pharmacy benefit manager, including, but not limited to, 14rebate aggregators and pharmacy services administrative 15organizations. 16    (c) The Department may examine any pharmacy benefit 17manager as often as the Department deems appropriate, but 18shall, at a minimum, conduct an examination of the 3 largest 19pharmacy benefit managers with the most covered individuals 20not less frequently than once every 5 years beginning in 2026, 21or following the conclusion of any market conduct exams 22already in progress for the 3 largest pharmacy benefit 23managers. In determining pharmacy benefit plan market share, 24the Department may consider, but is not limited to, the 25following:26        (1) the number of covered individuals;  HB1697 Enrolled- 32 -LRB104 03541 RTM 13564 b1        (2) the Illinois Market share;2        (3) the number of drug-related claims;3        (4) the total gross spending on drugs;4        (5) the aggregate amounts of rebates, fees, and 5    discounts remitted by the pharmacy benefit manager or 6    rebate aggregator;7        (6) the dispensing channel used;8        (7) the previous violations; and9        (8) the complaints received. 10(Source: P.A. 103-897, eff. 1-1-25.) 11    Section 25. The Illinois Public Aid Code is amended by 12changing Sections 5-5.12b and 5-36 as follows: 13    (305 ILCS 5/5-5.12b)14    Sec. 5-5.12b. Critical access care pharmacy program.15    (a) As used in this Section: 16    "Critical access care pharmacy" means an Illinois-based 17brick and mortar retail pharmacy that is located in Illinois 18that is owned by a person or entity with an ownership or 19control interest in a county with fewer than 50,000 residents 20and that owns fewer than 10 pharmacies, is either located in a 21county with fewer than 50,000 residents or in a county with 2250,000 or more residents and in an area within Illinois that is 23designated as a Medically Underserved Area by the Health 24Resources and Services Administration, an agency of the U.S.   HB1697 Enrolled- 33 -LRB104 03541 RTM 13564 b1Department of Health and Human Services and has attested and 2been approved by the Department for participation in the 3critical access care pharmacy program. 4    "Critical access care pharmacy program payment" means the 5number of individual prescriptions a critical access care 6pharmacy fills during that quarter multiplied by the lesser of 7the individual payment amount or the dispensing reimbursement 8rate made by the Department under the medical assistance 9program as of April 1, 2018. 10    "Individual payment amount" means the dividend of 1/4 of 11the annual amount appropriated for the critical access care 12pharmacy program by the number of prescriptions filled by all 13critical access care pharmacies reimbursed by Medicaid managed 14care organizations that quarter. 15    "Ownership or control interest" has the meaning given to 16"person with an ownership or control interest" in 42 CFR 17455.101. 18    (b) Subject to appropriations and federal approval, the 19Department shall establish a critical access care pharmacy 20program to ensure the sustainability of critical access 21pharmacies throughout the State of Illinois. 22    (c) The critical access care pharmacy program disbursed by 23the managed care plans shall not exceed $45,000,000 24$10,000,000 annually and individual payment amounts per 25prescription shall not exceed the brand name dispensing rate 26that the Department would have reimbursed to a critical access   HB1697 Enrolled- 34 -LRB104 03541 RTM 13564 b1care pharmacy under the Medical Assistance Program as of July 21, 2024 April 1, 2018. 3    (c-5) 340B pharmacies that are participants in the 4critical access care pharmacy program shall only be reimbursed 5for the actual acquisition costs of the 340B covered drugs 6dispensed to participants in the State's medical assistance 7program as defined in the Illinois Public Aid Code. 8    (d) Annually, beginning January 1, 2026 Quarterly, the 9Department shall determine the number of prescriptions filled 10by critical access care pharmacies reimbursed by Medicaid 11managed care organizations utilizing encounter data available 12to the Department. The Department shall determine the 13individual payment amount per prescription by dividing 1/4 of 14the annual amount appropriated for the critical access care 15pharmacy program by the number of prescriptions filled by all 16critical access care pharmacies reimbursed by Medicaid managed 17care organizations that quarter. If the individual payment 18amount per prescription as calculated using quarterly 19prescription amounts exceeds the reimbursement rate under the 20medical assistance program as of April 1, 2018, then the 21individual payment amount per prescription shall be the 22dispensing reimbursement rate under the medical assistance 23program as of April 1, 2018. 24    (e) Quarterly, the Department shall distribute to critical 25access care pharmacies a critical access care pharmacy program 26payment. The first payment shall be calculated utilizing the   HB1697 Enrolled- 35 -LRB104 03541 RTM 13564 b1encounter data from the last quarter of State fiscal year 22018. This payment shall sunset on December 31, 2025. 3    (f) Effective January 1, 2026, the Department shall issue 4a quarterly directed critical access care pharmacy program 5payment to critical access care pharmacies for any 6prescription drug dispensed to a managed care client. 7    (g) (f) The Department may adopt rules necessary to 8implement this Section. The rules may include, but are not 9limited to, permitting an Illinois-based brick and mortar 10pharmacy that owns fewer than 10 pharmacies to receive 11critical access care pharmacy program payments in the same 12manner as a critical access care pharmacy, regardless of 13whether the pharmacy meets the other requirements of a 14critical access care pharmacy in subsection (a) is located in 15a county with a population of less than 50,000. 16(Source: P.A. 100-587, eff. 6-4-18.) 17    (305 ILCS 5/5-36)18    Sec. 5-36. Pharmacy benefits. 19    (a)(1) The Department may enter into a contract with a 20third party on a fee-for-service reimbursement model for the 21purpose of administering pharmacy benefits as provided in this 22Section for members not enrolled in a Medicaid managed care 23organization; however, these services shall be approved by the 24Department. The Department shall ensure coordination of care 25between the third-party administrator and managed care   HB1697 Enrolled- 36 -LRB104 03541 RTM 13564 b1organizations as a consideration in any contracts established 2in accordance with this Section. Any managed care techniques, 3principles, or administration of benefits utilized in 4accordance with this subsection shall comply with State law. 5    (2) The following shall apply to contracts between 6entities contracting relating to the Department's third-party 7administrators and pharmacies: 8        (A) the Department shall approve any contract between 9    a third-party administrator and a pharmacy;10        (B) the Department's third-party administrator shall 11    not change the terms of a contract between a third-party 12    administrator and a pharmacy without written approval by 13    the Department; and14        (C) the Department's third-party administrator shall 15    not create, modify, implement, or indirectly establish any 16    fee on a pharmacy, pharmacist, or a recipient of medical 17    assistance without written approval by the Department. 18    (b) The provisions of this Section shall not apply to 19outpatient pharmacy services provided by a health care 20facility registered as a covered entity pursuant to 42 U.S.C. 21256b or any pharmacy owned by or contracted with the covered 22entity. A Medicaid managed care organization shall, either 23directly or through a pharmacy benefit manager, administer and 24reimburse outpatient pharmacy claims submitted by a health 25care facility registered as a covered entity pursuant to 42 26U.S.C. 256b, its owned pharmacies, and contracted pharmacies   HB1697 Enrolled- 37 -LRB104 03541 RTM 13564 b1in accordance with the contractual agreements the Medicaid 2managed care organization or its pharmacy benefit manager has 3with such facilities and pharmacies and in accordance with 4subsection (h-5). 5    (b-5) Any pharmacy benefit manager that contracts with a 6Medicaid managed care organization to administer and reimburse 7pharmacy claims as provided in this Section must be registered 8with the Director of Insurance in accordance with Section 9513b2 of the Illinois Insurance Code. A pharmacy benefit 10manager must comply with all provisions of Article XXXIIB of 11the Illinois Insurance Code to the extent that the provisions 12do not prevent the application of any provision of this 13Article or applicable federal law. Nothing in this Section 14shall be construed to limit the authority of the Illinois 15Department or the Inspector General to administer or enforce 16any provisions of this Section or any other Section in the 17Illinois Public Aid Code related to pharmacy benefit managers 18or Medicaid managed care entity. 19    (c) On at least an annual basis, the Director of the 20Department of Healthcare and Family Services shall submit a 21report beginning no later than one year after January 1, 2020 22(the effective date of Public Act 101-452) that provides an 23update on any contract, contract issues, formulary, dispensing 24fees, and maximum allowable cost concerns regarding a 25third-party administrator and managed care. The requirement 26for reporting to the General Assembly shall be satisfied by   HB1697 Enrolled- 38 -LRB104 03541 RTM 13564 b1filing copies of the report with the Speaker, the Minority 2Leader, and the Clerk of the House of Representatives and with 3the President, the Minority Leader, and the Secretary of the 4Senate. The Department shall take care that no proprietary 5information is included in the report required under this 6Section. 7    (d) (Blank). A pharmacy benefit manager shall notify the 8Department in writing of any activity, policy, or practice of 9the pharmacy benefit manager that directly or indirectly 10presents a conflict of interest that interferes with the 11discharge of the pharmacy benefit manager's duty to a managed 12care organization to exercise its contractual duties. 13"Conflict of interest" shall be defined by rule by the 14Department.15    (e) A pharmacy benefit manager shall, upon request, 16disclose to the Department the following information: 17        (1) whether the pharmacy benefit manager has a 18    contract, agreement, or other arrangement with a 19    pharmaceutical manufacturer to exclusively dispense or 20    provide a drug to a managed care organization's enrollees, 21    and the aggregate amounts of consideration of economic 22    benefits collected or received pursuant to that 23    arrangement; 24        (2) the percentage of claims payments made by the 25    pharmacy benefit manager to pharmacies owned, managed, or 26    controlled by the pharmacy benefit manager or any of the   HB1697 Enrolled- 39 -LRB104 03541 RTM 13564 b1    pharmacy benefit manager's management companies, parent 2    companies, subsidiary companies, or jointly held 3    companies; 4        (3) the aggregate amount of the fees or assessments 5    imposed on, or collected from, pharmacy providers; 6        (4) the average annualized percentage of revenue 7    collected by the pharmacy benefit manager as a result of 8    each contract it has executed with a managed care 9    organization contracted by the Department to provide 10    medical assistance benefits which is not paid by the 11    pharmacy benefit manager to pharmacy providers and 12    pharmaceutical manufacturers or labelers or in order to 13    perform administrative functions pursuant to its contracts 14    with managed care organizations; 15        (5) the total number of prescriptions dispensed under 16    each contract the pharmacy benefit manager has with a 17    managed care organization (MCO) contracted by the 18    Department to provide medical assistance benefits;19        (6) the aggregate wholesale acquisition cost for drugs 20    that were dispensed to enrollees in each MCO with which 21    the pharmacy benefit manager has a contract by any 22    pharmacy owned, managed, or controlled by the pharmacy 23    benefit manager or any of the pharmacy benefit manager's 24    management companies, parent companies, subsidiary 25    companies, or jointly-held companies; 26        (7) the aggregate amount of administrative fees that   HB1697 Enrolled- 40 -LRB104 03541 RTM 13564 b1    the pharmacy benefit manager received from all 2    pharmaceutical manufacturers for prescriptions dispensed 3    to MCO enrollees; 4        (8) for each MCO with which the pharmacy benefit 5    manager has a contract, the aggregate amount of payments 6    received by the pharmacy benefit manager from the MCO; 7        (9) for each MCO with which the pharmacy benefit 8    manager has a contract, the aggregate amount of 9    reimbursements the pharmacy benefit manager paid to 10    contracting pharmacies; and 11        (10) any other information considered necessary by the 12    Department. 13    (f) The information disclosed under subsection (e) shall 14include all retail, mail order, specialty, and compounded 15prescription products. All information made available to the 16Department under subsection (e) is confidential and not 17subject to disclosure under the Freedom of Information Act. 18All information made available to the Department under 19subsection (e) shall not be reported or distributed in any way 20that compromises its competitive, proprietary, or financial 21value. The information shall only be used by the Department to 22assess the contract, agreement, or other arrangements made 23between a pharmacy benefit manager and a pharmacy provider, 24pharmaceutical manufacturer or labeler, managed care 25organization, or other entity, as applicable. 26    (g) A pharmacy benefit manager shall disclose directly in   HB1697 Enrolled- 41 -LRB104 03541 RTM 13564 b1writing to a pharmacy provider or pharmacy services 2administrative organization contracting with the pharmacy 3benefit manager of any material change to a contract provision 4that affects the terms of the reimbursement, the process for 5verifying benefits and eligibility, dispute resolution, 6procedures for verifying drugs included on the formulary, and 7contract termination at least 30 days prior to the date of the 8change to the provision. The terms of this subsection shall be 9deemed met if the pharmacy benefit manager posts the 10information on a website, viewable by the public. A pharmacy 11service administration organization shall notify all contract 12pharmacies of any material change, as described in this 13subsection, within 2 days of notification. As used in this 14Section, "pharmacy services administrative organization" means 15an entity operating within the State that contracts with 16independent pharmacies to conduct business on their behalf 17with third-party payers. A pharmacy services administrative 18organization may provide administrative services to pharmacies 19and negotiate and enter into contracts with third-party payers 20or pharmacy benefit managers on behalf of pharmacies. 21    (h) A pharmacy benefit manager shall not include the 22following in a contract with a pharmacy provider: 23        (1) a provision prohibiting the provider from 24    informing a patient of a less costly alternative to a 25    prescribed medication; or 26        (2) a provision that prohibits the provider from   HB1697 Enrolled- 42 -LRB104 03541 RTM 13564 b1    dispensing a particular amount of a prescribed medication, 2    if the pharmacy benefit manager allows that amount to be 3    dispensed through a pharmacy owned or controlled by the 4    pharmacy benefit manager, unless the prescription drug is 5    subject to restricted distribution by the United States 6    Food and Drug Administration or requires special handling, 7    provider coordination, or patient education that cannot be 8    provided by a retail pharmacy. 9    (h-5) Unless required by law, a Medicaid managed care 10organization or pharmacy benefit manager administering or 11managing benefits on behalf of a Medicaid managed care 12organization shall not refuse to contract with a 340B entity 13or 340B pharmacy for refusing to accept less favorable payment 14terms or reimbursement methodologies when compared to 15similarly situated non-340B entities and shall not include in 16a contract with a 340B entity or 340B pharmacy a provision 17that: 18        (1) imposes any fee, chargeback, or rate adjustment 19    that is not similarly imposed on similarly situated 20    pharmacies that are not 340B entities or 340B pharmacies; 21        (2) imposes any fee, chargeback, or rate adjustment 22    that exceeds the fee, chargeback, or rate adjustment that 23    is not similarly imposed on similarly situated pharmacies 24    that are not 340B entities or 340B pharmacies; 25        (3) prevents or interferes with an individual's choice 26    to receive a prescription drug from a 340B entity or 340B   HB1697 Enrolled- 43 -LRB104 03541 RTM 13564 b1    pharmacy through any legally permissible means; 2        (4) excludes a 340B entity or 340B pharmacy from a 3    pharmacy network on the basis of whether the 340B entity 4    or 340B pharmacy participates in the 340B drug discount 5    program; 6        (5) prevents a 340B entity or 340B pharmacy from using 7    a drug purchased under the 340B drug discount program so 8    long as the drug recipient is a patient of the 340B entity; 9    nothing in this Section exempts a 340B pharmacy from 10    following the Department's preferred drug list or from any 11    prior approval requirements of the Department or the 12    Medicaid managed care organization that are imposed on the 13    drug for all pharmacies; or 14        (6) any other provision that discriminates against a 15    340B entity or 340B pharmacy by treating a 340B entity or 16    340B pharmacy differently than non-340B entities or 17    non-340B pharmacies for any reason relating to the 18    entity's participation in the 340B drug discount program. 19    A provision that violates this subsection in any contract 20between a Medicaid managed care organization or its pharmacy 21benefit manager and a 340B entity entered into, amended, or 22renewed after July 1, 2022 shall be void and unenforceable. 23    In this subsection (h-5):24    "340B entity" means a covered entity as defined in 42 25U.S.C. 256b(a)(4) authorized to participate in the 340B drug 26discount program.  HB1697 Enrolled- 44 -LRB104 03541 RTM 13564 b1    "340B pharmacy" means any pharmacy used to dispense 340B 2drugs for a covered entity, whether entity-owned or external. 3    (i) Nothing in this Section shall be construed to prohibit 4a pharmacy benefit manager from requiring the same 5reimbursement and terms and conditions for a pharmacy provider 6as for a pharmacy owned, controlled, or otherwise associated 7with the pharmacy benefit manager. 8    (j) A pharmacy benefit manager shall establish and 9implement a process for the resolution of disputes arising out 10of this Section, which shall be approved by the Department. 11    (k) The Department shall adopt rules establishing 12reasonable dispensing fees for fee-for-service payments in 13accordance with guidance or guidelines from the federal 14Centers for Medicare and Medicaid Services.15(Source: P.A. 102-558, eff. 8-20-21; 102-778, eff. 7-1-22; 16103-593, eff. 6-7-24.) 17    Section 30. The Juvenile Court Act of 1987 is amended by 18changing Section 5-515 as follows: 19    (705 ILCS 405/5-515)20    Sec. 5-515. Medical, and dental, and pharmaceutical 21treatment and care. 22    (a) At all times during temporary custody, detention or 23shelter care, the court may authorize a physician, a hospital 24or any other appropriate health care provider to provide   HB1697 Enrolled- 45 -LRB104 03541 RTM 13564 b1medical, dental or surgical procedures or pharmaceuticals if 2those procedures or pharmaceuticals are necessary to safeguard 3the minor's life or health. If the minor is covered under an 4existing medical or dental plan, the county shall be 5reimbursed for the expenses incurred for such services as if 6the minor were not held in temporary custody, detention, or 7shelter care.8    (b) If a provider of temporary custody, detention, or 9shelter care has a contract with a pharmacy benefit manager or 10a contract with an insurance company, health maintenance 11organization, limited health service organization, 12administrative services organization, or any other managed 13care organization or health insurance issuer where a pharmacy 14benefit manager administers the provider's coverage of, 15payment for, or formulary design for drugs necessary to 16safeguard the minor's life or health, the contract with the 17pharmacy benefit manager and the pharmacy benefit manager's 18activities shall be subject to Article XXXIIB of the Illinois 19Insurance Code and the authority of the Director of Insurance 20to enforce those provisions. The provider shall have all the 21rights of a plan sponsor under those provisions. 22(Source: P.A. 90-590, eff. 1-1-99.) 23    Section 35. The Unified Code of Corrections is amended by 24changing Section 3-2-2 as follows:   HB1697 Enrolled- 46 -LRB104 03541 RTM 13564 b1    (730 ILCS 5/3-2-2)  (from Ch. 38, par. 1003-2-2)2    Sec. 3-2-2. Powers and duties of the Department. 3    (1) In addition to the powers, duties, and 4responsibilities which are otherwise provided by law, the 5Department shall have the following powers:6        (a) To accept persons committed to it by the courts of 7    this State for care, custody, treatment, and 8    rehabilitation, and to accept federal prisoners and 9    noncitizens over whom the Office of the Federal Detention 10    Trustee is authorized to exercise the federal detention 11    function for limited purposes and periods of time.12        (b) To develop and maintain reception and evaluation 13    units for purposes of analyzing the custody and 14    rehabilitation needs of persons committed to it and to 15    assign such persons to institutions and programs under its 16    control or transfer them to other appropriate agencies. In 17    consultation with the Department of Alcoholism and 18    Substance Abuse (now the Department of Human Services), 19    the Department of Corrections shall develop a master plan 20    for the screening and evaluation of persons committed to 21    its custody who have alcohol or drug abuse problems, and 22    for making appropriate treatment available to such 23    persons; the Department shall report to the General 24    Assembly on such plan not later than April 1, 1987. The 25    maintenance and implementation of such plan shall be 26    contingent upon the availability of funds.  HB1697 Enrolled- 47 -LRB104 03541 RTM 13564 b1        (b-1) To create and implement, on January 1, 2002, a 2    pilot program to establish the effectiveness of 3    pupillometer technology (the measurement of the pupil's 4    reaction to light) as an alternative to a urine test for 5    purposes of screening and evaluating persons committed to 6    its custody who have alcohol or drug problems. The pilot 7    program shall require the pupillometer technology to be 8    used in at least one Department of Corrections facility. 9    The Director may expand the pilot program to include an 10    additional facility or facilities as he or she deems 11    appropriate. A minimum of 4,000 tests shall be included in 12    the pilot program. The Department must report to the 13    General Assembly on the effectiveness of the program by 14    January 1, 2003.15        (b-5) To develop, in consultation with the Illinois 16    State Police, a program for tracking and evaluating each 17    inmate from commitment through release for recording his 18    or her gang affiliations, activities, or ranks.19        (c) To maintain and administer all State correctional 20    institutions and facilities under its control and to 21    establish new ones as needed. Pursuant to its power to 22    establish new institutions and facilities, the Department 23    may, with the written approval of the Governor, authorize 24    the Department of Central Management Services to enter 25    into an agreement of the type described in subsection (d) 26    of Section 405-300 of the Department of Central Management   HB1697 Enrolled- 48 -LRB104 03541 RTM 13564 b1    Services Law. The Department shall designate those 2    institutions which shall constitute the State Penitentiary 3    System. The Department of Juvenile Justice shall maintain 4    and administer all State youth centers pursuant to 5    subsection (d) of Section 3-2.5-20. 6        Pursuant to its power to establish new institutions 7    and facilities, the Department may authorize the 8    Department of Central Management Services to accept bids 9    from counties and municipalities for the construction, 10    remodeling, or conversion of a structure to be leased to 11    the Department of Corrections for the purposes of its 12    serving as a correctional institution or facility. Such 13    construction, remodeling, or conversion may be financed 14    with revenue bonds issued pursuant to the Industrial 15    Building Revenue Bond Act by the municipality or county. 16    The lease specified in a bid shall be for a term of not 17    less than the time needed to retire any revenue bonds used 18    to finance the project, but not to exceed 40 years. The 19    lease may grant to the State the option to purchase the 20    structure outright.21        Upon receipt of the bids, the Department may certify 22    one or more of the bids and shall submit any such bids to 23    the General Assembly for approval. Upon approval of a bid 24    by a constitutional majority of both houses of the General 25    Assembly, pursuant to joint resolution, the Department of 26    Central Management Services may enter into an agreement   HB1697 Enrolled- 49 -LRB104 03541 RTM 13564 b1    with the county or municipality pursuant to such bid.2        (c-5) To build and maintain regional juvenile 3    detention centers and to charge a per diem to the counties 4    as established by the Department to defray the costs of 5    housing each minor in a center. In this subsection (c-5), 6    "juvenile detention center" means a facility to house 7    minors during pendency of trial who have been transferred 8    from proceedings under the Juvenile Court Act of 1987 to 9    prosecutions under the criminal laws of this State in 10    accordance with Section 5-805 of the Juvenile Court Act of 11    1987, whether the transfer was by operation of law or 12    permissive under that Section. The Department shall 13    designate the counties to be served by each regional 14    juvenile detention center.15        (d) To develop and maintain programs of control, 16    rehabilitation, and employment of committed persons within 17    its institutions.18        (d-5) To provide a pre-release job preparation program 19    for inmates at Illinois adult correctional centers. 20        (d-10) To provide educational and visitation 21    opportunities to committed persons within its institutions 22    through temporary access to content-controlled tablets 23    that may be provided as a privilege to committed persons 24    to induce or reward compliance. 25        (e) To establish a system of supervision and guidance 26    of committed persons in the community.  HB1697 Enrolled- 50 -LRB104 03541 RTM 13564 b1        (f) To establish in cooperation with the Department of 2    Transportation to supply a sufficient number of prisoners 3    for use by the Department of Transportation to clean up 4    the trash and garbage along State, county, township, or 5    municipal highways as designated by the Department of 6    Transportation. The Department of Corrections, at the 7    request of the Department of Transportation, shall furnish 8    such prisoners at least annually for a period to be agreed 9    upon between the Director of Corrections and the Secretary 10    of Transportation. The prisoners used on this program 11    shall be selected by the Director of Corrections on 12    whatever basis he deems proper in consideration of their 13    term, behavior and earned eligibility to participate in 14    such program - where they will be outside of the prison 15    facility but still in the custody of the Department of 16    Corrections. Prisoners convicted of first degree murder, 17    or a Class X felony, or armed violence, or aggravated 18    kidnapping, or criminal sexual assault, aggravated 19    criminal sexual abuse or a subsequent conviction for 20    criminal sexual abuse, or forcible detention, or arson, or 21    a prisoner adjudged a Habitual Criminal shall not be 22    eligible for selection to participate in such program. The 23    prisoners shall remain as prisoners in the custody of the 24    Department of Corrections and such Department shall 25    furnish whatever security is necessary. The Department of 26    Transportation shall furnish trucks and equipment for the   HB1697 Enrolled- 51 -LRB104 03541 RTM 13564 b1    highway cleanup program and personnel to supervise and 2    direct the program. Neither the Department of Corrections 3    nor the Department of Transportation shall replace any 4    regular employee with a prisoner.5        (g) To maintain records of persons committed to it and 6    to establish programs of research, statistics, and 7    planning.8        (h) To investigate the grievances of any person 9    committed to the Department and to inquire into any 10    alleged misconduct by employees or committed persons; and 11    for these purposes it may issue subpoenas and compel the 12    attendance of witnesses and the production of writings and 13    papers, and may examine under oath any witnesses who may 14    appear before it; to also investigate alleged violations 15    of a parolee's or releasee's conditions of parole or 16    release; and for this purpose it may issue subpoenas and 17    compel the attendance of witnesses and the production of 18    documents only if there is reason to believe that such 19    procedures would provide evidence that such violations 20    have occurred.21        If any person fails to obey a subpoena issued under 22    this subsection, the Director may apply to any circuit 23    court to secure compliance with the subpoena. The failure 24    to comply with the order of the court issued in response 25    thereto shall be punishable as contempt of court.26        (i) To appoint and remove the chief administrative   HB1697 Enrolled- 52 -LRB104 03541 RTM 13564 b1    officers, and administer programs of training and 2    development of personnel of the Department. Personnel 3    assigned by the Department to be responsible for the 4    custody and control of committed persons or to investigate 5    the alleged misconduct of committed persons or employees 6    or alleged violations of a parolee's or releasee's 7    conditions of parole shall be conservators of the peace 8    for those purposes, and shall have the full power of peace 9    officers outside of the facilities of the Department in 10    the protection, arrest, retaking, and reconfining of 11    committed persons or where the exercise of such power is 12    necessary to the investigation of such misconduct or 13    violations. This subsection shall not apply to persons 14    committed to the Department of Juvenile Justice under the 15    Juvenile Court Act of 1987 on aftercare release.16        (j) To cooperate with other departments and agencies 17    and with local communities for the development of 18    standards and programs for better correctional services in 19    this State.20        (k) To administer all moneys and properties of the 21    Department.22        (l) To report annually to the Governor on the 23    committed persons, institutions, and programs of the 24    Department.25        (l-5) (Blank).26        (m) To make all rules and regulations and exercise all   HB1697 Enrolled- 53 -LRB104 03541 RTM 13564 b1    powers and duties vested by law in the Department.2        (n) To establish rules and regulations for 3    administering a system of sentence credits, established in 4    accordance with Section 3-6-3, subject to review by the 5    Prisoner Review Board.6        (o) To administer the distribution of funds from the 7    State Treasury to reimburse counties where State penal 8    institutions are located for the payment of assistant 9    state's attorneys' salaries under Section 4-2001 of the 10    Counties Code.11        (p) To exchange information with the Department of 12    Human Services and the Department of Healthcare and Family 13    Services for the purpose of verifying living arrangements 14    and for other purposes directly connected with the 15    administration of this Code and the Illinois Public Aid 16    Code.17        (q) To establish a diversion program.18        The program shall provide a structured environment for 19    selected technical parole or mandatory supervised release 20    violators and committed persons who have violated the 21    rules governing their conduct while in work release. This 22    program shall not apply to those persons who have 23    committed a new offense while serving on parole or 24    mandatory supervised release or while committed to work 25    release.26        Elements of the program shall include, but shall not   HB1697 Enrolled- 54 -LRB104 03541 RTM 13564 b1    be limited to, the following:2            (1) The staff of a diversion facility shall 3        provide supervision in accordance with required 4        objectives set by the facility.5            (2) Participants shall be required to maintain 6        employment.7            (3) Each participant shall pay for room and board 8        at the facility on a sliding-scale basis according to 9        the participant's income.10            (4) Each participant shall:11                (A) provide restitution to victims in 12            accordance with any court order;13                (B) provide financial support to his 14            dependents; and15                (C) make appropriate payments toward any other 16            court-ordered obligations.17            (5) Each participant shall complete community 18        service in addition to employment.19            (6) Participants shall take part in such 20        counseling, educational, and other programs as the 21        Department may deem appropriate.22            (7) Participants shall submit to drug and alcohol 23        screening.24            (8) The Department shall promulgate rules 25        governing the administration of the program.26        (r) To enter into intergovernmental cooperation   HB1697 Enrolled- 55 -LRB104 03541 RTM 13564 b1    agreements under which persons in the custody of the 2    Department may participate in a county impact 3    incarceration program established under Section 3-6038 or 4    3-15003.5 of the Counties Code.5        (r-5) (Blank).6        (r-10) To systematically and routinely identify with 7    respect to each streetgang active within the correctional 8    system: (1) each active gang; (2) every existing 9    inter-gang affiliation or alliance; and (3) the current 10    leaders in each gang. The Department shall promptly 11    segregate leaders from inmates who belong to their gangs 12    and allied gangs. "Segregate" means no physical contact 13    and, to the extent possible under the conditions and space 14    available at the correctional facility, prohibition of 15    visual and sound communication. For the purposes of this 16    paragraph (r-10), "leaders" means persons who:17            (i) are members of a criminal streetgang;18            (ii) with respect to other individuals within the 19        streetgang, occupy a position of organizer, 20        supervisor, or other position of management or 21        leadership; and22            (iii) are actively and personally engaged in 23        directing, ordering, authorizing, or requesting 24        commission of criminal acts by others, which are 25        punishable as a felony, in furtherance of streetgang 26        related activity both within and outside of the   HB1697 Enrolled- 56 -LRB104 03541 RTM 13564 b1        Department of Corrections.2    "Streetgang", "gang", and "streetgang related" have the 3    meanings ascribed to them in Section 10 of the Illinois 4    Streetgang Terrorism Omnibus Prevention Act.5        (s) To operate a super-maximum security institution, 6    in order to manage and supervise inmates who are 7    disruptive or dangerous and provide for the safety and 8    security of the staff and the other inmates.9        (t) To monitor any unprivileged conversation or any 10    unprivileged communication, whether in person or by mail, 11    telephone, or other means, between an inmate who, before 12    commitment to the Department, was a member of an organized 13    gang and any other person without the need to show cause or 14    satisfy any other requirement of law before beginning the 15    monitoring, except as constitutionally required. The 16    monitoring may be by video, voice, or other method of 17    recording or by any other means. As used in this 18    subdivision (1)(t), "organized gang" has the meaning 19    ascribed to it in Section 10 of the Illinois Streetgang 20    Terrorism Omnibus Prevention Act.21        As used in this subdivision (1)(t), "unprivileged 22    conversation" or "unprivileged communication" means a 23    conversation or communication that is not protected by any 24    privilege recognized by law or by decision, rule, or order 25    of the Illinois Supreme Court.26        (u) To establish a Women's and Children's Pre-release   HB1697 Enrolled- 57 -LRB104 03541 RTM 13564 b1    Community Supervision Program for the purpose of providing 2    housing and services to eligible female inmates, as 3    determined by the Department, and their newborn and young 4    children.5        (u-5) To issue an order, whenever a person committed 6    to the Department absconds or absents himself or herself, 7    without authority to do so, from any facility or program 8    to which he or she is assigned. The order shall be 9    certified by the Director, the Supervisor of the 10    Apprehension Unit, or any person duly designated by the 11    Director, with the seal of the Department affixed. The 12    order shall be directed to all sheriffs, coroners, and 13    police officers, or to any particular person named in the 14    order. Any order issued pursuant to this subdivision 15    (1)(u-5) shall be sufficient warrant for the officer or 16    person named in the order to arrest and deliver the 17    committed person to the proper correctional officials and 18    shall be executed the same as criminal process. 19        (u-6) To appoint a point of contact person who shall 20    receive suggestions, complaints, or other requests to the 21    Department from visitors to Department institutions or 22    facilities and from other members of the public.23        (v) To do all other acts necessary to carry out the 24    provisions of this Chapter.25    (2) The Department of Corrections shall by January 1, 261998, consider building and operating a correctional facility   HB1697 Enrolled- 58 -LRB104 03541 RTM 13564 b1within 100 miles of a county of over 2,000,000 inhabitants, 2especially a facility designed to house juvenile participants 3in the impact incarceration program.4    (3) When the Department lets bids for contracts for 5medical services to be provided to persons committed to 6Department facilities by a health maintenance organization, 7medical service corporation, or other health care provider, 8the bid may only be let to a health care provider that has 9obtained an irrevocable letter of credit or performance bond 10issued by a company whose bonds have an investment grade or 11higher rating by a bond rating organization.12    (3.5) If the Department has a contract with a pharmacy 13benefit manager or a contract with an insurance company, 14health maintenance organization, limited health service 15organization, administrative services organization, or any 16other managed care entity or health insurance issuer where a 17pharmacy benefit manager administers the provider's coverage 18of, payment for, or formulary design for drugs necessary to 19safeguard the minor's life or health, the contract with the 20pharmacy benefit manager and the pharmacy benefit manager's 21activities shall be subject to Article XXXIIB of the Illinois 22Insurance Code and the authority of the Director of Insurance 23to enforce those provisions. The provider shall have all the 24rights of a plan sponsor under those provisions. 25    (4) When the Department lets bids for contracts for food 26or commissary services to be provided to Department   HB1697 Enrolled- 59 -LRB104 03541 RTM 13564 b1facilities, the bid may only be let to a food or commissary 2services provider that has obtained an irrevocable letter of 3credit or performance bond issued by a company whose bonds 4have an investment grade or higher rating by a bond rating 5organization.6    (5) On and after the date 6 months after August 16, 2013 7(the effective date of Public Act 98-488), as provided in the 8Executive Order 1 (2012) Implementation Act, all of the 9powers, duties, rights, and responsibilities related to State 10healthcare purchasing under this Code that were transferred 11from the Department of Corrections to the Department of 12Healthcare and Family Services by Executive Order 3 (2005) are 13transferred back to the Department of Corrections; however, 14powers, duties, rights, and responsibilities related to State 15healthcare purchasing under this Code that were exercised by 16the Department of Corrections before the effective date of 17Executive Order 3 (2005) but that pertain to individuals 18resident in facilities operated by the Department of Juvenile 19Justice are transferred to the Department of Juvenile Justice. 20    (6) The Department of Corrections shall provide lactation 21or nursing mothers rooms for personnel of the Department. The 22rooms shall be provided in each facility of the Department 23that employs nursing mothers. Each individual lactation room 24must: 25        (i) contain doors that lock; 26        (ii) have an "Occupied" sign for each door;   HB1697 Enrolled- 60 -LRB104 03541 RTM 13564 b1        (iii) contain electrical outlets for plugging in 2    breast pumps; 3        (iv) have sufficient lighting and ventilation; 4        (v) contain comfortable chairs; 5        (vi) contain a countertop or table for all necessary 6    supplies for lactation; 7        (vii) contain a wastebasket and chemical cleaners to 8    wash one's hands and to clean the surfaces of the 9    countertop or table; 10        (viii) have a functional sink; 11        (ix) have a minimum of one refrigerator for storage of 12    the breast milk; and 13        (x) receive routine daily maintenance. 14(Source: P.A. 102-350, eff. 8-13-21; 102-535, eff. 1-1-22; 15102-538, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1030, eff. 165-27-22; 103-834, eff. 1-1-25.) 17    Section 40. The County Jail Act is amended by changing 18Section 17 as follows: 19    (730 ILCS 125/17)  (from Ch. 75, par. 117)20    Sec. 17. Bedding, clothing, fuel, and medical aid; 21reimbursement for medical expenses. The Warden of the jail 22shall furnish necessary bedding, clothing, fuel, and medical 23services for all committed persons under his charge, and keep 24an accurate account of the same. When services that result in   HB1697 Enrolled- 61 -LRB104 03541 RTM 13564 b1qualified medical expenses are required by any person held in 2custody, the county, private hospital, physician or any public 3agency which provides such services shall be entitled to 4obtain reimbursement from the county for the cost of such 5services. The county board of a county may adopt an ordinance 6or resolution providing for reimbursement for the cost of 7those services at the Department of Healthcare and Family 8Services' rates for medical assistance. To the extent that 9such person is reasonably able to pay for such care, including 10reimbursement from any insurance program or from other medical 11benefit programs available to such person, he or she shall 12reimburse the county or arresting authority. If such person 13has already been determined eligible for medical assistance 14under the Illinois Public Aid Code at the time the person is 15detained, the cost of such services, to the extent such cost 16exceeds $500, shall be reimbursed by the Department of 17Healthcare and Family Services under that Code. A 18reimbursement under any public or private program authorized 19by this Section shall be paid to the county or arresting 20authority to the same extent as would have been obtained had 21the services been rendered in a non-custodial environment.22    The sheriff or his or her designee may cause an 23application for medical assistance under the Illinois Public 24Aid Code to be completed for an arrestee who is a hospital 25inpatient. If such arrestee is determined eligible, he or she 26shall receive medical assistance under the Code for hospital   HB1697 Enrolled- 62 -LRB104 03541 RTM 13564 b1inpatient services only. An arresting authority shall be 2responsible for any qualified medical expenses relating to the 3arrestee until such time as the arrestee is placed in the 4custody of the sheriff. However, the arresting authority shall 5not be so responsible if the arrest was made pursuant to a 6request by the sheriff. When medical expenses are required by 7any person held in custody, the county shall be entitled to 8obtain reimbursement from the County Jail Medical Costs Fund 9to the extent moneys are available from the Fund. To the extent 10that the person is reasonably able to pay for that care, 11including reimbursement from any insurance program or from 12other medical benefit programs available to the person, he or 13she shall reimburse the county.14    For the purposes of this Section, "arresting authority" 15means a unit of local government, other than a county, which 16employs peace officers and whose peace officers have made the 17arrest of a person. For the purposes of this Section, 18"qualified medical expenses" include medical and hospital 19services but do not include (i) expenses incurred for medical 20care or treatment provided to a person on account of a 21self-inflicted injury incurred prior to or in the course of an 22arrest, (ii) expenses incurred for medical care or treatment 23provided to a person on account of a health condition of that 24person which existed prior to the time of his or her arrest, or 25(iii) expenses for hospital inpatient services for arrestees 26enrolled for medical assistance under the Illinois Public Aid   HB1697 Enrolled- 63 -LRB104 03541 RTM 13564 b1Code.2    If a jail or a unit of local government operating the jail 3has a contract with a pharmacy benefit manager or a contract 4with an insurance company, health maintenance organization, 5limited health service organization, administrative services 6organization, or any other managed care organization or health 7insurance issuer where a pharmacy benefit manager administers 8coverage of, payment for, or formulary design for drugs 9necessary to safeguard the life or health of any person in 10custody, that contract and the pharmacy benefit manager's 11activities shall be subject to Article XXXIIB of the Illinois 12Insurance Code and the authority of the Director of Insurance 13to enforce those provisions. The jail or unit of local 14government shall have all the rights of a plan sponsor under 15those provisions. 16(Source: P.A. 103-745, eff. 1-1-25.) 17    Section 99. Effective date. This Act takes effect on 18January 1, 2026, except that this Section, Section 10, and the 19changes to Sections 513b2 and 513b3 of the Illinois Insurance 20Code take effect upon becoming law.


================================================================================

Raw Text:
Full Text of HB1697 ILGA.GOV HB1697 - 104th General Assembly HB1697 EnrolledLRB104 03541 RTM 13564 b1    AN ACT concerning State government. 2    Be it enacted by the People of the State of Illinois, 3represented in the General Assembly: 4    Section 1. This Act may be referred to as the Prescription 5Drug Affordability Act. 6    Section 5. The State Employees Group Insurance Act of 1971 7is amended by changing Section 6.11 as follows: 8    (5 ILCS 375/6.11)9    Sec. 6.11. Required health benefits; Illinois Insurance 10Code requirements. The program of health benefits shall 11provide the post-mastectomy care benefits required to be 12covered by a policy of accident and health insurance under 13Section 356t of the Illinois Insurance Code. The program of 14health benefits shall provide the coverage required under 15Sections 356g, 356g.5, 356g.5-1, 356m, 356q, 356u, 356u.10, 16356w, 356x, 356z.2, 356z.4, 356z.4a, 356z.5, 356z.6, 356z.8, 17356z.9, 356z.10, 356z.11, 356z.12, 356z.13, 356z.14, 356z.15, 18356z.17, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 19356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 20356z.51, 356z.53, 356z.54, 356z.55, 356z.56, 356z.57, 356z.59, 21356z.60, 356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 22356z.70, and 356z.71, 356z.74, 356z.76, and 356z.77 of the   HB1697 Enrolled- 2 -LRB104 03541 RTM 13564 b1Illinois Insurance Code. The program of health benefits must 2comply with Sections 155.22a, 155.37, 355b, 356z.19, 370c, and 3370c.1 and Article XXXIIB of the Illinois Insurance Code. The 4program of health benefits shall provide the coverage required 5under Section 356m of the Illinois Insurance Code and, for the 6employees of the State Employee Group Insurance Program only, 7the coverage as also provided in Section 6.11B of this Act. The 8Department of Insurance shall enforce the requirements of this 9Section with respect to Sections 370c and 370c.1 and Article 10XXXIIB of the Illinois Insurance Code; all other requirements 11of this Section shall be enforced by the Department of Central 12Management Services.13    Rulemaking authority to implement Public Act 95-1045, if 14any, is conditioned on the rules being adopted in accordance 15with all provisions of the Illinois Administrative Procedure 16Act and all rules and procedures of the Joint Committee on 17Administrative Rules; any purported rule not so adopted, for 18whatever reason, is unauthorized. 19(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 20102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 211-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-768, 22eff. 1-1-24; 102-804, eff. 1-1-23; 102-813, eff. 5-13-22; 23102-816, eff. 1-1-23; 102-860, eff. 1-1-23; 102-1093, eff. 241-1-23; 102-1117, eff. 1-13-23; 103-8, eff. 1-1-24; 103-84, 25eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, eff. 1-1-24; 26103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 103-551, eff.   HB1697 Enrolled- 3 -LRB104 03541 RTM 13564 b18-11-23; 103-605, eff. 7-1-24; 103-718, eff. 7-19-24; 103-751, 2eff. 8-2-24; 103-870, eff. 1-1-25; 103-914, eff. 1-1-25; 3103-918, eff. 1-1-25; 103-951, eff. 1-1-25; 103-1024, eff. 41-1-25; revised 11-26-24.) 5    Section 10. The Department of Commerce and Economic 6Opportunity Law of the Civil Administrative Code of Illinois 7is amended by changing Section 605-60 as follows: 8    (20 ILCS 605/605-60)9    Sec. 605-60. DCEO Projects Fund. 10    (a) The DCEO Projects Fund is created as a trust fund in 11the State treasury. The Department is authorized to accept and 12deposit into the Fund moneys received from any gifts, grants, 13transfers, or other sources, public or private, unless deposit 14into a different fund is otherwise mandated. 15    (b) Subject to appropriation, the Department shall use 16moneys in the Fund to make grants or loans to and enter into 17contracts with units of local government, local and regional 18economic development corporations, retail associations, and 19not-for-profit organizations for municipal development 20projects, for the specific purposes established by the terms 21and conditions of the gift, grant, or award, and for related 22administrative expenses. As used in this Section, the term 23"municipal development projects" includes, but is not limited 24to, grants for reducing food insecurity in urban and rural   HB1697 Enrolled- 4 -LRB104 03541 RTM 13564 b1areas.2    (c) In this subsection, "rural tract" and "urban tract" 3have the meanings given to those terms in Section 5 of the 4Grocery Initiative Act.5    Subject to appropriation, the Department shall use moneys 6deposited into the Fund pursuant to Section 513b2 of the 7Illinois Insurance Code to make a grant to a statewide retail 8association representing pharmacies to promote access to 9pharmacies and pharmacist services. Grant funds under this 10subsection shall be made available to the following 11beneficiaries: 12        (1) critical access care pharmacies as defined in 13    Section 5-5.12b of the Illinois Public Aid Code;14        (2) retail pharmacies with a physical location in 15    Illinois owned by a person or entity with an ownership or 16    control interest in fewer than 10 pharmacies;17        (3) retail pharmacies with a physical location in a 18    county in Illinois with fewer than 50,000 residents;19        (4) retail pharmacies with a physical location in a 20    county in Illinois with 50,000 or more residents and in an 21    area within Illinois that is designated by the United 22    States Department of Health and Human Services as either: 23    (A) a Medically Underserved Area, including Governor's 24    Exceptions; or (B) a Medically Underserved Population, 25    including Governor's Exceptions;26        (5) pharmacies whose claims constitute 65% or greater   HB1697 Enrolled- 5 -LRB104 03541 RTM 13564 b1    for Medicaid services and at least 80% of their total 2    claims are for pharmacy services administered in Illinois;3        (6) a pharmacy located in an Illinois census tract 4    that meets both of the following poverty and population 5    density and pharmacy accessibility standards:6            (A) the census tract has either: (i) 20% or more of 7        its population living below the poverty guidelines 8        updated periodically in the Federal Register by the 9        U.S. Department of Health and Human Services under the 10        authority of 42 U.S.C. 9902(2); or (ii) a median 11        household income of less than 80% of the median income 12        of the nearest metropolitan area; and13            (B) the census tract has at least 33% of its 14        population living one mile or more from the pharmacy 15        for urban tracts or more than 10 miles from the 16        pharmacy for rural tracts.17    At least annually, the Department shall file with the 18Governor and the General Assembly a report that includes: 19        (1) the number of beneficiaries who applied for 20    funding; 21        (2) the number of beneficiaries who received funding; 22    and 23        (3) the pharmacies that were awarded funding, 24    including the location, the amount of funding, and the 25    subsection category or categories under which the pharmacy 26    qualified.  HB1697 Enrolled- 6 -LRB104 03541 RTM 13564 b1(Source: P.A. 103-588, eff. 6-5-24.) 2    Section 12. The State Finance Act is amended by adding 3Section 5.1030 as follows: 4    (30 ILCS 105/5.1030 new)5    Sec. 5.1030. The Prescription Drug Affordability Fund. 6    Section 15. The School Code is amended by changing Section 710-22.3f as follows: 8    (105 ILCS 5/10-22.3f)9    Sec. 10-22.3f. Required health benefits. Insurance 10protection and benefits for employees shall provide the 11post-mastectomy care benefits required to be covered by a 12policy of accident and health insurance under Section 356t and 13the coverage required under Sections 356g, 356g.5, 356g.5-1, 14356m, 356q, 356u, 356u.10, 356w, 356x, 356z.4, 356z.4a, 15356z.6, 356z.8, 356z.9, 356z.11, 356z.12, 356z.13, 356z.14, 16356z.15, 356z.22, 356z.25, 356z.26, 356z.29, 356z.30, 356z.32, 17356z.33, 356z.36, 356z.40, 356z.41, 356z.45, 356z.46, 356z.47, 18356z.51, 356z.53, 356z.54, 356z.56, 356z.57, 356z.59, 356z.60, 19356z.61, 356z.62, 356z.64, 356z.67, 356z.68, and 356z.70, and 20356z.71, 356z.74, and 356z.77 of the Illinois Insurance Code. 21Insurance policies shall comply with Section 356z.19 of the 22Illinois Insurance Code. The coverage shall comply with   HB1697 Enrolled- 7 -LRB104 03541 RTM 13564 b1Sections 155.22a, 355b, and 370c and Article XXXIIB of the 2Illinois Insurance Code. The Department of Insurance shall 3enforce the requirements of this Section. 4    Rulemaking authority to implement Public Act 95-1045, if 5any, is conditioned on the rules being adopted in accordance 6with all provisions of the Illinois Administrative Procedure 7Act and all rules and procedures of the Joint Committee on 8Administrative Rules; any purported rule not so adopted, for 9whatever reason, is unauthorized. 10(Source: P.A. 102-30, eff. 1-1-22; 102-103, eff. 1-1-22; 11102-203, eff. 1-1-22; 102-306, eff. 1-1-22; 102-642, eff. 121-1-22; 102-665, eff. 10-8-21; 102-731, eff. 1-1-23; 102-804, 13eff. 1-1-23; 102-813, eff. 5-13-22; 102-816, eff. 1-1-23; 14102-860, eff. 1-1-23; 102-1093, eff. 1-1-23; 102-1117, eff. 151-13-23; 103-84, eff. 1-1-24; 103-91, eff. 1-1-24; 103-420, 16eff. 1-1-24; 103-445, eff. 1-1-24; 103-535, eff. 8-11-23; 17103-551, eff. 8-11-23; 103-605, eff. 7-1-24; 103-718, eff. 187-19-24; 103-751, eff. 8-2-24; 103-914, eff. 1-1-25; 103-918, 19eff. 1-1-25; 103-1024, eff. 1-1-25; revised 11-26-24.) 20    Section 20. The Illinois Insurance Code is amended by 21changing Sections 513b1, 513b2, and 513b3 and by adding 22Section 513b1.1 as follows: 23    (215 ILCS 5/513b1)24    Sec. 513b1. Pharmacy benefit manager contracts.  HB1697 Enrolled- 8 -LRB104 03541 RTM 13564 b1    (a) As used in this Section: 2    "340B drug discount program" means the program established 3under Section 340B of the federal Public Health Service Act, 442 U.S.C. 256b. 5    "340B entity" means a covered entity as defined in 42 6U.S.C. 256b(a)(4) authorized to participate in the 340B drug 7discount program. 8    "340B pharmacy" means any pharmacy used to dispense 340B 9drugs for a covered entity, whether entity-owned or external.10    "Affiliate" means a person or entity that directly or 11indirectly through one or more intermediaries controls or is 12controlled by, or is under common control with, the person or 13entity specified. The location of a person or entity's 14domicile, whether in Illinois or a foreign or alien 15jurisdiction, does not affect the person or entity's status as 16an affiliate.17    "Biological product" has the meaning ascribed to that term 18in Section 19.5 of the Pharmacy Practice Act.19    "Brand name drug" means a drug that has been approved 20under 42 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 21marketed, sold, or distributed under a proprietary, 22trademark-protected name.23    "Complex or chronic medical condition" means a physical, 24behavioral, or developmental condition that has no known cure, 25is progressive, or can be debilitating or fatal if unmanaged 26or untreated.  HB1697 Enrolled- 9 -LRB104 03541 RTM 13564 b1    "Covered individual" means a member, participant, 2enrollee, contract holder, policyholder, or beneficiary of a 3health benefit plan who is provided a drug benefit by the 4health benefit plan.5    "Critical access pharmacy" means a critical access care 6pharmacy as defined in Section 5-5.12b of the Illinois Public 7Aid Code.8    "Drugs" has the meaning ascribed to that term in Section 3 9of the Pharmacy Practice Act and includes biological products.10    "Generic drug" means a drug that has been approved under 1142 U.S.C. 262 or 21 U.S.C. 355(c), as applicable, and is 12marketed, sold, or distributed directly or indirectly to the 13retail class of trade with labeling, packaging (other than 14repackaging as the listed drug in blister packs, unit doses, 15or similar packaging for use in institutions), product code, 16labeler code, trade name, or trademark that differs from that 17of the brand name drug.18    "Health benefit plan" means a policy, contract, 19certificate, or agreement entered into, offered, or issued by 20an insurer to provide, deliver, arrange for, pay for, or 21reimburse any of the costs of physical, mental, or behavioral 22health care services. Notwithstanding Sections 122-1 through 23122-4 of this Code, "health benefit plan" includes self-funded 24employee welfare benefit plans. Notwithstanding Sections 122-1 25through 122-4 of this Code, "health benefit plan" includes 26self-funded employee welfare benefit plans except for   HB1697 Enrolled- 10 -LRB104 03541 RTM 13564 b1self-funded multiemployer plans that are not nonfederal 2government plans.3    "Maximum allowable cost" means the maximum amount that a 4pharmacy benefit manager will reimburse a pharmacy for the 5cost of a drug. 6    "Maximum allowable cost list" means a list of drugs for 7which a maximum allowable cost has been established by a 8pharmacy benefit manager. 9    "Pharmacy benefit manager" means a person, business, or 10entity, including a wholly or partially owned or controlled 11subsidiary of a pharmacy benefit manager, that provides claims 12processing services or other prescription drug or device 13services, or both, for health benefit plans.14    "Pharmacy" has the meaning given to that term in Section 3 15of the Pharmacy Practice Act. 16    "Pharmacy services" means the provision of any services 17listed within the definition of "practice of pharmacy" under 18subsection (d) of Section 3 of the Pharmacy Practice Act.19    "Rare medical condition" means a physical, behavioral, or 20developmental condition that affects fewer than 200,000 21individuals in the United States or approximately 1 in 1,500 22individuals worldwide.23    "Rebate" means a discount or pricing concession based on 24drug utilization or administration that is paid by the 25manufacturer to a pharmacy benefit manager or its client. 26    "Rebate aggregator" means a person or entity, including   HB1697 Enrolled- 11 -LRB104 03541 RTM 13564 b1group purchasing organizations, that negotiate rebates or 2other fees with drug manufacturers on behalf or for the 3benefit of a pharmacy benefit manager or its client and may 4also be involved in contracts that entitle the rebate 5aggregator or its client to receive rebates or other fees from 6drug manufacturers based on drug utilization or 7administration. 8    "Retail price" means the price an individual without 9prescription drug coverage would pay at a retail pharmacy, not 10including a pharmacist dispensing fee. 11    "Specialty drug" means a drug that:12        (1) is prescribed for a person with a complex or 13    chronic medical condition or a rare medical condition;14        (2) has limited or exclusive distribution; and15        (3) requires both:16            (A) specialized product handling by the dispensing 17        pharmacy or administration by the dispensing pharmacy; 18        and19            (B) specialized clinical care, including frequent 20        dosing adjustments, intensive clinical monitoring, or 21        expanded services for patients, including intensive 22        patient counseling, education, or ongoing clinical 23        support beyond traditional dispensing activities, such 24        as individualized disease and therapy management to 25        support improved health outcomes.26    "Spread pricing" means the model of drug pricing in which   HB1697 Enrolled- 12 -LRB104 03541 RTM 13564 b1the pharmacy benefit manager charges a health benefit plan a 2contracted price for drugs, and the contracted price for the 3drugs differs from the amount the pharmacy benefit manager 4directly or indirectly pays the pharmacist or pharmacy for the 5drugs, pharmacist services, or drug and dispensing fees.6    "Steer" includes, but is not limited to:7        (1) requiring a covered individual to only use a 8    pharmacy, including a mail-order or specialty pharmacy, in 9    which the pharmacy benefit manager or its affiliate 10    maintains an ownership interest or control;11        (2) offering or implementing a plan design that 12    encourages a covered individual to only use a pharmacy in 13    which the pharmacy benefit manager or an affiliate 14    maintains an ownership interest or control, if the plan 15    design increases costs for the covered individual. This 16    includes a plan design that requires a covered individual 17    to pay higher costs or an increased share of costs for a 18    drug or drug-related service if the covered individual 19    uses a pharmacy that is not owned or controlled by the 20    pharmacy benefit manager or its affiliate.21        (3) reimbursing a pharmacy or pharmacist for a drug 22    and pharmacist service in an amount less than the amount 23    that the pharmacy benefit manager reimburses itself or an 24    affiliate, including affiliated manufacturers or joint 25    ventures for providing the same drug or service. 26    "Third-party payer" means any entity that pays for   HB1697 Enrolled- 13 -LRB104 03541 RTM 13564 b1prescription drugs on behalf of a patient other than a health 2care provider or sponsor of a plan subject to regulation under 3Medicare Part D, 42 U.S.C. 1395w-101 et seq.4    (a-5) In this Article, references to an "insurer" or 5"health insurer" shall include commercial private health 6insurance issuers, managed care organizations, managed care 7community networks, and any other third-party payer that 8contracts with pharmacy benefit managers or with the 9Department of Healthcare and Family Services to provide 10benefits or services under the Medicaid program or to 11otherwise engage in the administration or payment of pharmacy 12benefits. However, the terms do not refer to the plan sponsor 13of a self-funded, single-employer employee welfare benefit 14plan or self-funded multiemployer plan subject to 29 U.S.C. 151144.16    (b) A contract between a health insurer and a pharmacy 17benefit manager must require that the pharmacy benefit 18manager: 19        (1) Update maximum allowable cost pricing information 20    at least every 7 calendar days. 21        (2) Maintain a process that will, in a timely manner, 22    eliminate drugs from maximum allowable cost lists or 23    modify drug prices to remain consistent with changes in 24    pricing data used in formulating maximum allowable cost 25    prices and product availability. 26        (3) Provide access to its maximum allowable cost list   HB1697 Enrolled- 14 -LRB104 03541 RTM 13564 b1    to each pharmacy or pharmacy services administrative 2    organization subject to the maximum allowable cost list. 3    Access may include a real-time pharmacy website portal to 4    be able to view the maximum allowable cost list. As used in 5    this Section, "pharmacy services administrative 6    organization" means an entity operating within the State 7    that contracts with independent pharmacies to conduct 8    business on their behalf with third-party payers. A 9    pharmacy services administrative organization may provide 10    administrative services to pharmacies and negotiate and 11    enter into contracts with third-party payers or pharmacy 12    benefit managers on behalf of pharmacies. 13        (4) Provide a process by which a contracted pharmacy 14    can appeal the provider's reimbursement for a drug subject 15    to maximum allowable cost pricing. The appeals process 16    must, at a minimum, include the following: 17            (A) A requirement that a contracted pharmacy has 18        14 calendar days after the applicable fill date to 19        appeal a maximum allowable cost if the reimbursement 20        for the drug is less than the net amount that the 21        network provider paid to the supplier of the drug. 22            (B) A requirement that a pharmacy benefit manager 23        must respond to a challenge within 14 calendar days of 24        the contracted pharmacy making the claim for which the 25        appeal has been submitted.26            (C) A telephone number and e-mail address or   HB1697 Enrolled- 15 -LRB104 03541 RTM 13564 b1        website to network providers, at which the provider 2        can contact the pharmacy benefit manager to process 3        and submit an appeal.4            (D) A requirement that, if an appeal is denied, 5        the pharmacy benefit manager must provide the reason 6        for the denial and the name and the national drug code 7        number from national or regional wholesalers.8            (E) A requirement that, if an appeal is sustained, 9        the pharmacy benefit manager must make an adjustment 10        in the drug price effective the date the challenge is 11        resolved and make the adjustment applicable to all 12        similarly situated network pharmacy providers, as 13        determined by the managed care organization or 14        pharmacy benefit manager. 15        (5) Allow a plan sponsor or insurer whose coverage is 16    administered by the contracting with a pharmacy benefit 17    manager an annual right to audit compliance with the terms 18    of the contract by the pharmacy benefit manager, 19    including, but not limited to, full disclosure of any and 20    all rebate amounts secured, whether product specific or 21    generalized rebates, that were provided to the pharmacy 22    benefit manager by a pharmaceutical manufacturer. The cost 23    of the audit shall be borne exclusively by the pharmacy 24    benefit manager. 25        (6) Allow a plan sponsor or insurer whose coverage is 26    administered by the contracting with a pharmacy benefit   HB1697 Enrolled- 16 -LRB104 03541 RTM 13564 b1    manager to request that the pharmacy benefit manager 2    disclose the actual amounts paid by the pharmacy benefit 3    manager to the pharmacy.4        (7) Provide notice to the plan sponsor or the insurer 5    party contracting with the pharmacy benefit manager of any 6    consideration that the pharmacy benefit manager receives 7    from the manufacturer for dispense as written 8    prescriptions once a generic or biologically similar 9    product becomes available. 10    (c) In order to place a particular prescription drug on a 11maximum allowable cost list, the pharmacy benefit manager 12must, at a minimum, ensure that: 13        (1) if the drug is a generically equivalent drug, it 14    is listed as therapeutically equivalent and 15    pharmaceutically equivalent "A" or "B" rated in the United 16    States Food and Drug Administration's most recent version 17    of the "Orange Book" or have an NR or NA rating by 18    Medi-Span, Gold Standard, or a similar rating by a 19    nationally recognized reference; 20        (2) the drug is available for purchase by each 21    pharmacy in the State from national or regional 22    wholesalers operating in Illinois; and 23        (3) the drug is not obsolete. 24    (d) A pharmacy benefit manager is prohibited from limiting 25a pharmacist's ability to disclose whether the cost-sharing 26obligation exceeds the retail price for a covered prescription   HB1697 Enrolled- 17 -LRB104 03541 RTM 13564 b1drug, and the availability of a more affordable alternative 2drug, if one is available in accordance with Section 42 of the 3Pharmacy Practice Act. 4    (e) A health insurer or pharmacy benefit manager shall not 5require a covered individual an insured to make a payment for a 6prescription drug at the point of sale in an amount that 7exceeds the lesser of: 8        (1) the applicable cost-sharing amount; or9        (2) the retail price of the drug in the absence of 10    prescription drug coverage;11        (3) the discounted price presented by the covered 12    individual through a no-cost drug program or drug 13    manufacturer voucher provided by or for the covered 14    individual at the point of sale; or15        (4) the discounted price presented by the covered 16    individual through a discounted health care services plan 17    provided by or for the covered individual at the point of 18    sale. 19    (f) Unless required by law, a contract between a pharmacy 20benefit manager or third-party payer and a 340B entity or 340B 21pharmacy shall not contain any provision that: 22        (1) distinguishes between drugs purchased through the 23    340B drug discount program and other drugs when 24    determining reimbursement or reimbursement methodologies, 25    or contains otherwise less favorable payment terms or 26    reimbursement methodologies for 340B entities or 340B   HB1697 Enrolled- 18 -LRB104 03541 RTM 13564 b1    pharmacies when compared to similarly situated non-340B 2    entities; 3        (2) imposes any fee, chargeback, or rate adjustment 4    that is not similarly imposed on similarly situated 5    pharmacies that are not 340B entities or 340B pharmacies; 6        (3) imposes any fee, chargeback, or rate adjustment 7    that exceeds the fee, chargeback, or rate adjustment that 8    is not similarly imposed on similarly situated pharmacies 9    that are not 340B entities or 340B pharmacies; 10        (4) prevents or interferes with an individual's choice 11    to receive a covered prescription drug from a 340B entity 12    or 340B pharmacy through any legally permissible means, 13    except that nothing in this paragraph shall prohibit the 14    establishment of differing copayments or other 15    cost-sharing amounts within the health benefit plan for 16    covered individuals persons who acquire covered 17    prescription drugs from a nonpreferred or nonparticipating 18    provider; 19        (5) excludes a 340B entity or 340B pharmacy from a 20    pharmacy network on any basis that includes consideration 21    of whether the 340B entity or 340B pharmacy participates 22    in the 340B drug discount program; 23        (6) prevents a 340B entity or 340B pharmacy from using 24    a drug purchased under the 340B drug discount program; or 25        (7) any other provision that discriminates against a 26    340B entity or 340B pharmacy by treating the 340B entity   HB1697 Enrolled- 19 -LRB104 03541 RTM 13564 b1    or 340B pharmacy differently than non-340B entities or 2    non-340B pharmacies for any reason relating to the 3    entity's participation in the 340B drug discount program. 4    As used in this subsection, "pharmacy benefit manager" and 5"third-party payer" do not include pharmacy benefit managers 6and third-party payers acting on behalf of a Medicaid program.7    (f-5) A pharmacy benefit manager or an affiliate acting on 8its behalf shall not conduct spread pricing.9    (f-10) A pharmacy benefit manager or an affiliate acting 10on its behalf shall not steer a covered individual. Existing 11agreements entered into before the effective date of this 12amendatory Act of the 104th General Assembly shall supersede 13this subsection until the termination of the current term of 14such agreement.15    (f-15) A pharmacy benefit manager or affiliated rebate 16aggregator must remit no less than 100% of any amounts paid by 17a pharmaceutical manufacturer, wholesaler, or other 18distributor of a drug, including, but not limited to, rebates, 19group purchasing fees, and other fees, to the health benefit 20plan sponsor, covered individual, or employer. Records of 21rebates and fees remitted from the pharmacy benefit manager or 22rebate aggregator must be disclosed to the Department annually 23in a format to be specified by the Department. The records 24received by the Department shall be considered confidential 25and privileged for all purposes, including for purposes of the 26Freedom of Information Act, shall not be subject to subpoena   HB1697 Enrolled- 20 -LRB104 03541 RTM 13564 b1from any private party, and shall not be admissible as 2evidence in a civil action.3    (f-20) A pharmacy benefit manager or an affiliate acting 4on its behalf is prohibited from limiting a covered 5individual's access to drugs from a pharmacy or pharmacist 6enrolled with the health benefit plan under the terms offered 7to all pharmacies in the plan coverage area by designating the 8covered drug as a specialty drug contrary to the definition in 9this Section.10    (f-25) The contract between the pharmacy benefit manager 11and the insurer or health benefit plan sponsor must allow and 12provide for the pharmacy benefit manager's compliance with an 13audit at least once per calendar year of the rebate and fee 14records remitted from a pharmacy benefit manager or its 15affiliated party to a health benefit plan. This audit may be 16incorporated into the audit under paragraph (5) of subsection 17(b) of this Section. Contracts with rebate aggregators, 18pharmacy services administrative organizations, pharmacies, or 19drug manufacturers must be available for audit by health 20benefit plan sponsors, insurers, or their designees at least 21once per plan year. Audits shall be performed by an auditor 22selected by the health benefit plan sponsor, insurer, or its 23designee. Health benefit plan sponsors and insurers shall give 24the pharmacy benefit manager a complete copy of the audit and 25the pharmacy benefit manager shall provide a complete copy of 26those findings to the Department within 60 days of initial   HB1697 Enrolled- 21 -LRB104 03541 RTM 13564 b1receipt. Rebate contracts with rebate aggregators, pharmacy 2services administrative organizations, pharmacies, or drug 3manufacturers shall be available for audit by health benefit 4plan sponsor, insurer, or designee. Nothing in this Section 5shall limit the Department's ability to access the books and 6records and any and all copies thereof of pharmacy benefit 7managers, their affiliates, or affiliated rebate aggregators. 8The records received by the Department shall be considered 9confidential and privileged for all purposes, including for 10purposes of the Freedom of Information Act, shall not be 11subject to subpoena from any private party, and shall not be 12admissible as evidence in a civil action. 13    (g) A violation of this Section by a pharmacy benefit 14manager constitutes an unfair or deceptive act or practice in 15the business of insurance under Section 424. 16    (h) A provision that violates subsection (f) in a contract 17between a pharmacy benefit manager or a third-party payer and 18a 340B entity that is entered into, amended, or renewed after 19July 1, 2022 shall be void and unenforceable. This subsection 20and subsection (f) do not apply to a contract directly between 21a 340B entity and the plan sponsor of a self-funded, 22single-employer or multiemployer employee welfare benefit plan 23subject to 29 U.S.C. 1144. 24    (i)(1) A pharmacy benefit manager may not retaliate 25against a pharmacist or pharmacy for disclosing information in 26a court, in an administrative hearing, before a legislative   HB1697 Enrolled- 22 -LRB104 03541 RTM 13564 b1commission or committee, or in any other proceeding, if the 2pharmacist or pharmacy has reasonable cause to believe that 3the disclosed information is evidence of a violation of a 4State or federal law, rule, or regulation.5    (2) A pharmacy benefit manager may not retaliate against a 6pharmacist or pharmacy for disclosing information to a 7government or law enforcement agency, if the pharmacist or 8pharmacy has reasonable cause to believe that the disclosed 9information is evidence of a violation of a State or federal 10law, rule, or regulation.11    (3) A pharmacist or pharmacy shall make commercially 12reasonable efforts to limit the disclosure of confidential and 13proprietary information.14    (4) Retaliatory actions against a pharmacy or pharmacist 15include cancellation of, restriction of, or refusal to renew 16or offer a contract to a pharmacy solely because the pharmacy 17or pharmacist has:18        (A) made disclosures of information that the 19    pharmacist or pharmacy has reasonable cause to believe is 20    evidence of a violation of a State or federal law, rule, or 21    regulation;22        (B) filed complaints with the plan or pharmacy benefit 23    manager; or24        (C) filed complaints against the plan or pharmacy 25    benefit manager with the Department.26    (j) This Section applies to contracts entered into or   HB1697 Enrolled- 23 -LRB104 03541 RTM 13564 b1renewed on or after July 1, 2022 and, unless provided 2otherwise in this Section or in the Illinois Public Aid Code, 3applies to pharmacy benefit managers that are contracted with 4a Medicaid managed care entity on or after January 1, 2026. 5    (k) This Section applies to any health benefit group or 6individual policy of accident and health insurance or managed 7care plan that provides coverage for prescription drugs and 8that is amended, delivered, issued, or renewed on or after 9July 1, 2020. The changes made to this Section by this 10amendatory Act of the 104th General Assembly shall apply with 11respect to any health benefit plan that provides coverage for 12drugs that is amended, delivered, issued, or renewed on or 13after January 1, 2026. 14    (l) A pharmacy benefit manager is responsible for 15compliance with all State requirements applicable to pharmacy 16benefit managers even if an action or responsibility of a 17pharmacy benefit manager is delegated to or completed by an 18affiliate. 19(Source: P.A. 102-778, eff. 7-1-22; 103-154, eff. 6-30-23; 20103-453, eff. 8-4-23.) 21    (215 ILCS 5/513b1.1 new)22    Sec. 513b1.1. Pharmacy benefit manager reporting 23requirements.24    (a) A pharmacy benefit manager that provides services for 25a health benefit plan must submit an annual report no later   HB1697 Enrolled- 24 -LRB104 03541 RTM 13564 b1than September 1, to the Department, each health benefit plan 2sponsor, and each insurer that includes the following:3        (1) data on the health benefit plan including:4            (A) a list of drugs including corresponding 5        information on therapeutic class, brand name, generic 6        name, or specialty drug name;7            (B) number of covered individuals;8            (C) number of drug-related claims;9            (D) dosage units;10            (E) dispensing channel used;11            (F) average wholesale acquisition cost per drug; 12        and13            (G) total out-of-pocket spending by deidentified 14        covered individual per drug, per transaction;15        (2) amount received by the health benefit plan in 16    rebates, fees, or discounts related to drug utilization or 17    spending;18        (3) total gross spending on drugs by the health 19    benefit plan;20        (4) total net spending, gross spending less 21    administrative portion of the medical loss ratio, on drugs 22    by the health benefit plan;23        (5) the amount paid by the health benefit plan to the 24    pharmacy benefit manager for reimbursement cost of a drug 25    and service per transaction;26        (6) the amount a pharmacy benefit manager paid for   HB1697 Enrolled- 25 -LRB104 03541 RTM 13564 b1    pharmacists' services and drugs rendered related to the 2    health benefit plan per transaction, including, but not 3    limited to, any dispensing fee;4        (7) the specific rebate amount received by the 5    pharmacy benefit manager per transaction, the amount of 6    the rebates passed through to the health benefit plan per 7    transaction, and the amount of the rebates passed on to 8    covered individuals at the point of sale that reduced the 9    covered individuals' applicable deductible, copayment, 10    coinsurance, or other cost-sharing amount per transaction;11        (8) any information collected from drug manufacturers 12    pertaining to copayment assistance to the extent such 13    information is collected;14        (9) any compensation paid to brokers, consultants, 15    advisors, or any other individual or firm for referrals, 16    consideration, or retention by the health benefit plan;17        (10) explanation of benefit design parameters 18    encouraging or requiring covered individuals to use 19    affiliated pharmacies, percentage of drugs charged by 20    these pharmacies, and a list of drugs dispensed by 21    affiliated pharmacies with their associated costs; and22        (11) a complete copy of each unredacted contract the 23    pharmacy benefit manager has with the health benefit plan 24    sponsor or insurer.25    (b) Annual reports pursuant to subsection (a):26        (1) must be written in plain language to ensure ease   HB1697 Enrolled- 26 -LRB104 03541 RTM 13564 b1    of reading and accessibility;2        (2) must only contain summary health information to 3    ensure plan, coverage, or covered individual information 4    remains private and confidential;5        (3) upon request by a covered individual, must be 6    available in summary format and provide aggregated 7    information to help covered individuals understand their 8    health benefit plan's drug coverage; and9        (4) must be filed with the Department no later than 10    September 1 of each year via the Systems for Electronic 11    Rates & Forms Filing (SERFF). The filing shall include the 12    summary version of the report described in paragraph (3) 13    of this subsection, which shall be marked for public 14    access.15    The Department may share all reports with an established 16institution of higher education in this State for the creation 17of a pharmacist dispensing cost report to be produced 18annually. This annual pharmacist dispensing cost report shall 19provide a survey of the average cost of dispensing a 20prescription for pharmacists in Illinois. The institution of 21higher education shall have the ability to request additional 22information from pharmacists for its analysis. The institution 23of higher education shall issue the report to the General 24Assembly no later than December 31, 2026 and annually 25thereafter. 26    (c) A pharmacy benefit manager may petition the Department   HB1697 Enrolled- 27 -LRB104 03541 RTM 13564 b1for a filing submission extension. The Director may grant or 2deny the extension within 5 business days.3    (d) Failure by a pharmacy benefit manager to submit all 4required elements in an annual report to the Department may 5result in a fine levied by the Director not to exceed $10,000 6per day, per offense. Funds derived from fines levied shall be 7deposited into the Insurance Producer Administration Fund. 8Fine information shall be posted on the Department's website.9    (e) A pharmacy benefit manager found in violation of 10subsection (a) or paragraph (4) of subsection (b) may request 11a hearing from the Director within 10 days of receipt of the 12Director's order, or, if the violation is found in a market 13conduct examination, as provided in Section 132 of this Code.14    (f) Except for the summary version, the annual reports 15submitted by pharmacy benefit managers shall be considered 16confidential and privileged for all purposes, including for 17purposes of the Freedom of Information Act, shall not be 18subject to subpoena from any private party, and shall not be 19admissible as evidence in a civil action.20    (g) A copy of an adverse decision against a pharmacy 21benefit manager for failing to submit an annual report to the 22Department must be posted to the Department's website.23    (h) Nothing in this Section shall be construed as 24permitting a pharmacy benefit manager to avoid or otherwise 25fail to comply with the reporting requirements set forth in 26Section 5-36 of the Illinois Public Aid Code.   HB1697 Enrolled- 28 -LRB104 03541 RTM 13564 b1    (215 ILCS 5/513b2)2    Sec. 513b2. Licensure requirements.3    (a) Beginning on July 1, 2020, to conduct business in this 4State, a pharmacy benefit manager must register with the 5Director. To initially register or renew a registration, a 6pharmacy benefit manager shall submit: 7        (1) A nonrefundable fee not to exceed $500. 8        (2) A copy of the registrant's corporate charter, 9    articles of incorporation, or other charter document. 10        (3) A completed registration form adopted by the 11    Director containing: 12            (A) The name and address of the registrant. 13            (B) The name, address, and official position of 14        each officer and director of the registrant. 15    (b) The registrant shall report any change in information 16required under this Section to the Director in writing within 1760 days after the change occurs. 18    (c) Upon receipt of a completed registration form, the 19required documents, and the registration fee, the Director 20shall issue a registration certificate. The certificate may be 21in paper or electronic form, and shall clearly indicate the 22expiration date of the registration. Registration certificates 23are nontransferable. 24    (d) A registration certificate is valid for 2 years after 25its date of issue. The Director shall adopt by rule an initial   HB1697 Enrolled- 29 -LRB104 03541 RTM 13564 b1registration fee not to exceed $500 and a registration renewal 2fee not to exceed $500, both of which shall be nonrefundable. 3Total fees may not exceed the cost of administering this 4Section. 5    (e) The Department shall adopt any rules necessary to 6implement this Section. 7    (f) On or before August 1, 2025, the pharmacy benefit 8manager shall submit a report to the Department that lists the 9name of each health benefit plan it administers, provides the 10number of covered individuals for each health benefit plan as 11of the date of submission, and provides the total number of 12covered individuals across all health benefit plans the 13pharmacy benefit manager administers. On or before September 141, 2025, a registered pharmacy benefit manager, as a condition 15of its authority to transact business in this State, must 16submit to the Department an amount equal to $15 or an alternate 17amount as determined by the Director by rule per covered 18individual enrolled by the pharmacy benefit manager in this 19State, as detailed in the report submitted to the Department 20under this subsection, during the preceding calendar year. On 21or before September 1, 2026 and each September 1 thereafter, 22payments submitted under this subsection shall be based on the 23number of covered individuals reported to the Department in 24Section 513b1.1. 25    (g) All amounts collected under this Section shall be 26deposited into the Prescription Drug Affordability Fund, which   HB1697 Enrolled- 30 -LRB104 03541 RTM 13564 b1is hereby created as a special fund in the State treasury. Of 2the amounts collected under this Section each fiscal year, the 3Department shall transfer the first $25,000,000 into the DCEO 4Projects Fund for grants to pharmacies under Section 605-60 of 5the Department of Commerce and Economic Opportunity Law. 6(Source: P.A. 101-452, eff. 1-1-20.) 7    (215 ILCS 5/513b3)8    Sec. 513b3. Examination. 9    (a) The Director, or his or her designee, may examine a 10registered pharmacy benefit manager related to all of its 11lines of business, including government programs, under the 12Director's jurisdiction in accordance with Sections 132-132.7. 13If the Director or the examiners find that the pharmacy 14benefit manager has violated this Article or any other 15insurance-related or health benefits-related laws, rules, or 16regulations under the Director's jurisdiction because of the 17manner in which the pharmacy benefit manager has conducted 18business on behalf of a health insurer or plan sponsor, then, 19unless the health insurer or plan sponsor is included in the 20examination and has been afforded the same opportunity to 21request or participate in a hearing on the examination report, 22the examination report shall not allege a violation by the 23health insurer or plan sponsor and the Director's order based 24on the report shall not impose any requirements, prohibitions, 25or penalties on the health insurer or plan sponsor. Nothing in   HB1697 Enrolled- 31 -LRB104 03541 RTM 13564 b1this Section shall prevent the Director from using any 2information obtained during the examination of an 3administrator to examine, investigate, or take other 4appropriate regulatory or legal action with respect to a 5health insurer or plan sponsor.6    (b) The examination requirement for the pharmacy benefit 7manager to provide convenient and free access to all books and 8records under Sections 132 and 132.4 of this Code includes, at 9the Director's discretion, unredacted copies furnished 10electronically to the Director's market conduct surveillance 11personnel or examiners. Access must include information 12related to third-party entities affiliated or contracted with 13the pharmacy benefit manager, including, but not limited to, 14rebate aggregators and pharmacy services administrative 15organizations. 16    (c) The Department may examine any pharmacy benefit 17manager as often as the Department deems appropriate, but 18shall, at a minimum, conduct an examination of the 3 largest 19pharmacy benefit managers with the most covered individuals 20not less frequently than once every 5 years beginning in 2026, 21or following the conclusion of any market conduct exams 22already in progress for the 3 largest pharmacy benefit 23managers. In determining pharmacy benefit plan market share, 24the Department may consider, but is not limited to, the 25following:26        (1) the number of covered individuals;  HB1697 Enrolled- 32 -LRB104 03541 RTM 13564 b1        (2) the Illinois Market share;2        (3) the number of drug-related claims;3        (4) the total gross spending on drugs;4        (5) the aggregate amounts of rebates, fees, and 5    discounts remitted by the pharmacy benefit manager or 6    rebate aggregator;7        (6) the dispensing channel used;8        (7) the previous violations; and9        (8) the complaints received. 10(Source: P.A. 103-897, eff. 1-1-25.) 11    Section 25. The Illinois Public Aid Code is amended by 12changing Sections 5-5.12b and 5-36 as follows: 13    (305 ILCS 5/5-5.12b)14    Sec. 5-5.12b. Critical access care pharmacy program.15    (a) As used in this Section: 16    "Critical access care pharmacy" means an Illinois-based 17brick and mortar retail pharmacy that is located in Illinois 18that is owned by a person or entity with an ownership or 19control interest in a county with fewer than 50,000 residents 20and that owns fewer than 10 pharmacies, is either located in a 21county with fewer than 50,000 residents or in a county with 2250,000 or more residents and in an area within Illinois that is 23designated as a Medically Underserved Area by the Health 24Resources and Services Administration, an agency of the U.S.   HB1697 Enrolled- 33 -LRB104 03541 RTM 13564 b1Department of Health and Human Services and has attested and 2been approved by the Department for participation in the 3critical access care pharmacy program. 4    "Critical access care pharmacy program payment" means the 5number of individual prescriptions a critical access care 6pharmacy fills during that quarter multiplied by the lesser of 7the individual payment amount or the dispensing reimbursement 8rate made by the Department under the medical assistance 9program as of April 1, 2018. 10    "Individual payment amount" means the dividend of 1/4 of 11the annual amount appropriated for the critical access care 12pharmacy program by the number of prescriptions filled by all 13critical access care pharmacies reimbursed by Medicaid managed 14care organizations that quarter. 15    "Ownership or control interest" has the meaning given to 16"person with an ownership or control interest" in 42 CFR 17455.101. 18    (b) Subject to appropriations and federal approval, the 19Department shall establish a critical access care pharmacy 20program to ensure the sustainability of critical access 21pharmacies throughout the State of Illinois. 22    (c) The critical access care pharmacy program disbursed by 23the managed care plans shall not exceed $45,000,000 24$10,000,000 annually and individual payment amounts per 25prescription shall not exceed the brand name dispensing rate 26that the Department would have reimbursed to a critical access   HB1697 Enrolled- 34 -LRB104 03541 RTM 13564 b1care pharmacy under the Medical Assistance Program as of July 21, 2024 April 1, 2018. 3    (c-5) 340B pharmacies that are participants in the 4critical access care pharmacy program shall only be reimbursed 5for the actual acquisition costs of the 340B covered drugs 6dispensed to participants in the State's medical assistance 7program as defined in the Illinois Public Aid Code. 8    (d) Annually, beginning January 1, 2026 Quarterly, the 9Department shall determine the number of prescriptions filled 10by critical access care pharmacies reimbursed by Medicaid 11managed care organizations utilizing encounter data available 12to the Department. The Department shall determine the 13individual payment amount per prescription by dividing 1/4 of 14the annual amount appropriated for the critical access care 15pharmacy program by the number of prescriptions filled by all 16critical access care pharmacies reimbursed by Medicaid managed 17care organizations that quarter. If the individual payment 18amount per prescription as calculated using quarterly 19prescription amounts exceeds the reimbursement rate under the 20medical assistance program as of April 1, 2018, then the 21individual payment amount per prescription shall be the 22dispensing reimbursement rate under the medical assistance 23program as of April 1, 2018. 24    (e) Quarterly, the Department shall distribute to critical 25access care pharmacies a critical access care pharmacy program 26payment. The first payment shall be calculated utilizing the   HB1697 Enrolled- 35 -LRB104 03541 RTM 13564 b1encounter data from the last quarter of State fiscal year 22018. This payment shall sunset on December 31, 2025. 3    (f) Effective January 1, 2026, the Department shall issue 4a quarterly directed critical access care pharmacy program 5payment to critical access care pharmacies for any 6prescription drug dispensed to a managed care client. 7    (g) (f) The Department may adopt rules necessary to 8implement this Section. The rules may include, but are not 9limited to, permitting an Illinois-based brick and mortar 10pharmacy that owns fewer than 10 pharmacies to receive 11critical access care pharmacy program payments in the same 12manner as a critical access care pharmacy, regardless of 13whether the pharmacy meets the other requirements of a 14critical access care pharmacy in subsection (a) is located in 15a county with a population of less than 50,000. 16(Source: P.A. 100-587, eff. 6-4-18.) 17    (305 ILCS 5/5-36)18    Sec. 5-36. Pharmacy benefits. 19    (a)(1) The Department may enter into a contract with a 20third party on a fee-for-service reimbursement model for the 21purpose of administering pharmacy benefits as provided in this 22Section for members not enrolled in a Medicaid managed care 23organization; however, these services shall be approved by the 24Department. The Department shall ensure coordination of care 25between the third-party administrator and managed care   HB1697 Enrolled- 36 -LRB104 03541 RTM 13564 b1organizations as a consideration in any contracts established 2in accordance with this Section. Any managed care techniques, 3principles, or administration of benefits utilized in 4accordance with this subsection shall comply with State law. 5    (2) The following shall apply to contracts between 6entities contracting relating to the Department's third-party 7administrators and pharmacies: 8        (A) the Department shall approve any contract between 9    a third-party administrator and a pharmacy;10        (B) the Department's third-party administrator shall 11    not change the terms of a contract between a third-party 12    administrator and a pharmacy without written approval by 13    the Department; and14        (C) the Department's third-party administrator shall 15    not create, modify, implement, or indirectly establish any 16    fee on a pharmacy, pharmacist, or a recipient of medical 17    assistance without written approval by the Department. 18    (b) The provisions of this Section shall not apply to 19outpatient pharmacy services provided by a health care 20facility registered as a covered entity pursuant to 42 U.S.C. 21256b or any pharmacy owned by or contracted with the covered 22entity. A Medicaid managed care organization shall, either 23directly or through a pharmacy benefit manager, administer and 24reimburse outpatient pharmacy claims submitted by a health 25care facility registered as a covered entity pursuant to 42 26U.S.C. 256b, its owned pharmacies, and contracted pharmacies   HB1697 Enrolled- 37 -LRB104 03541 RTM 13564 b1in accordance with the contractual agreements the Medicaid 2managed care organization or its pharmacy benefit manager has 3with such facilities and pharmacies and in accordance with 4subsection (h-5). 5    (b-5) Any pharmacy benefit manager that contracts with a 6Medicaid managed care organization to administer and reimburse 7pharmacy claims as provided in this Section must be registered 8with the Director of Insurance in accordance with Section 9513b2 of the Illinois Insurance Code. A pharmacy benefit 10manager must comply with all provisions of Article XXXIIB of 11the Illinois Insurance Code to the extent that the provisions 12do not prevent the application of any provision of this 13Article or applicable federal law. Nothing in this Section 14shall be construed to limit the authority of the Illinois 15Department or the Inspector General to administer or enforce 16any provisions of this Section or any other Section in the 17Illinois Public Aid Code related to pharmacy benefit managers 18or Medicaid managed care entity. 19    (c) On at least an annual basis, the Director of the 20Department of Healthcare and Family Services shall submit a 21report beginning no later than one year after January 1, 2020 22(the effective date of Public Act 101-452) that provides an 23update on any contract, contract issues, formulary, dispensing 24fees, and maximum allowable cost concerns regarding a 25third-party administrator and managed care. The requirement 26for reporting to the General Assembly shall be satisfied by   HB1697 Enrolled- 38 -LRB104 03541 RTM 13564 b1filing copies of the report with the Speaker, the Minority 2Leader, and the Clerk of the House of Representatives and with 3the President, the Minority Leader, and the Secretary of the 4Senate. The Department shall take care that no proprietary 5information is included in the report required under this 6Section. 7    (d) (Blank). A pharmacy benefit manager shall notify the 8Department in writing of any activity, policy, or practice of 9the pharmacy benefit manager that directly or indirectly 10presents a conflict of interest that interferes with the 11discharge of the pharmacy benefit manager's duty to a managed 12care organization to exercise its contractual duties. 13"Conflict of interest" shall be defined by rule by the 14Department.15    (e) A pharmacy benefit manager shall, upon request, 16disclose to the Department the following information: 17        (1) whether the pharmacy benefit manager has a 18    contract, agreement, or other arrangement with a 19    pharmaceutical manufacturer to exclusively dispense or 20    provide a drug to a managed care organization's enrollees, 21    and the aggregate amounts of consideration of economic 22    benefits collected or received pursuant to that 23    arrangement; 24        (2) the percentage of claims payments made by the 25    pharmacy benefit manager to pharmacies owned, managed, or 26    controlled by the pharmacy benefit manager or any of the   HB1697 Enrolled- 39 -LRB104 03541 RTM 13564 b1    pharmacy benefit manager's management companies, parent 2    companies, subsidiary companies, or jointly held 3    companies; 4        (3) the aggregate amount of the fees or assessments 5    imposed on, or collected from, pharmacy providers; 6        (4) the average annualized percentage of revenue 7    collected by the pharmacy benefit manager as a result of 8    each contract it has executed with a managed care 9    organization contracted by the Department to provide 10    medical assistance benefits which is not paid by the 11    pharmacy benefit manager to pharmacy providers and 12    pharmaceutical manufacturers or labelers or in order to 13    perform administrative functions pursuant to its contracts 14    with managed care organizations; 15        (5) the total number of prescriptions dispensed under 16    each contract the pharmacy benefit manager has with a 17    managed care organization (MCO) contracted by the 18    Department to provide medical assistance benefits;19        (6) the aggregate wholesale acquisition cost for drugs 20    that were dispensed to enrollees in each MCO with which 21    the pharmacy benefit manager has a contract by any 22    pharmacy owned, managed, or controlled by the pharmacy 23    benefit manager or any of the pharmacy benefit manager's 24    management companies, parent companies, subsidiary 25    companies, or jointly-held companies; 26        (7) the aggregate amount of administrative fees that   HB1697 Enrolled- 40 -LRB104 03541 RTM 13564 b1    the pharmacy benefit manager received from all 2    pharmaceutical manufacturers for prescriptions dispensed 3    to MCO enrollees; 4        (8) for each MCO with which the pharmacy benefit 5    manager has a contract, the aggregate amount of payments 6    received by the pharmacy benefit manager from the MCO; 7        (9) for each MCO with which the pharmacy benefit 8    manager has a contract, the aggregate amount of 9    reimbursements the pharmacy benefit manager paid to 10    contracting pharmacies; and 11        (10) any other information considered necessary by the 12    Department. 13    (f) The information disclosed under subsection (e) shall 14include all retail, mail order, specialty, and compounded 15prescription products. All information made available to the 16Department under subsection (e) is confidential and not 17subject to disclosure under the Freedom of Information Act. 18All information made available to the Department under 19subsection (e) shall not be reported or distributed in any way 20that compromises its competitive, proprietary, or financial 21value. The information shall only be used by the Department to 22assess the contract, agreement, or other arrangements made 23between a pharmacy benefit manager and a pharmacy provider, 24pharmaceutical manufacturer or labeler, managed care 25organization, or other entity, as applicable. 26    (g) A pharmacy benefit manager shall disclose directly in   HB1697 Enrolled- 41 -LRB104 03541 RTM 13564 b1writing to a pharmacy provider or pharmacy services 2administrative organization contracting with the pharmacy 3benefit manager of any material change to a contract provision 4that affects the terms of the reimbursement, the process for 5verifying benefits and eligibility, dispute resolution, 6procedures for verifying drugs included on the formulary, and 7contract termination at least 30 days prior to the date of the 8change to the provision. The terms of this subsection shall be 9deemed met if the pharmacy benefit manager posts the 10information on a website, viewable by the public. A pharmacy 11service administration organization shall notify all contract 12pharmacies of any material change, as described in this 13subsection, within 2 days of notification. As used in this 14Section, "pharmacy services administrative organization" means 15an entity operating within the State that contracts with 16independent pharmacies to conduct business on their behalf 17with third-party payers. A pharmacy services administrative 18organization may provide administrative services to pharmacies 19and negotiate and enter into contracts with third-party payers 20or pharmacy benefit managers on behalf of pharmacies. 21    (h) A pharmacy benefit manager shall not include the 22following in a contract with a pharmacy provider: 23        (1) a provision prohibiting the provider from 24    informing a patient of a less costly alternative to a 25    prescribed medication; or 26        (2) a provision that prohibits the provider from   HB1697 Enrolled- 42 -LRB104 03541 RTM 13564 b1    dispensing a particular amount of a prescribed medication, 2    if the pharmacy benefit manager allows that amount to be 3    dispensed through a pharmacy owned or controlled by the 4    pharmacy benefit manager, unless the prescription drug is 5    subject to restricted distribution by the United States 6    Food and Drug Administration or requires special handling, 7    provider coordination, or patient education that cannot be 8    provided by a retail pharmacy. 9    (h-5) Unless required by law, a Medicaid managed care 10organization or pharmacy benefit manager administering or 11managing benefits on behalf of a Medicaid managed care 12organization shall not refuse to contract with a 340B entity 13or 340B pharmacy for refusing to accept less favorable payment 14terms or reimbursement methodologies when compared to 15similarly situated non-340B entities and shall not include in 16a contract with a 340B entity or 340B pharmacy a provision 17that: 18        (1) imposes any fee, chargeback, or rate adjustment 19    that is not similarly imposed on similarly situated 20    pharmacies that are not 340B entities or 340B pharmacies; 21        (2) imposes any fee, chargeback, or rate adjustment 22    that exceeds the fee, chargeback, or rate adjustment that 23    is not similarly imposed on similarly situated pharmacies 24    that are not 340B entities or 340B pharmacies; 25        (3) prevents or interferes with an individual's choice 26    to receive a prescription drug from a 340B entity or 340B   HB1697 Enrolled- 43 -LRB104 03541 RTM 13564 b1    pharmacy through any legally permissible means; 2        (4) excludes a 340B entity or 340B pharmacy from a 3    pharmacy network on the basis of whether the 340B entity 4    or 340B pharmacy participates in the 340B drug discount 5    program; 6        (5) prevents a 340B entity or 340B pharmacy from using 7    a drug purchased under the 340B drug discount program so 8    long as the drug recipient is a patient of the 340B entity; 9    nothing in this Section exempts a 340B pharmacy from 10    following the Department's preferred drug list or from any 11    prior approval requirements of the Department or the 12    Medicaid managed care organization that are imposed on the 13    drug for all pharmacies; or 14        (6) any other provision that discriminates against a 15    340B entity or 340B pharmacy by treating a 340B entity or 16    340B pharmacy differently than non-340B entities or 17    non-340B pharmacies for any reason relating to the 18    entity's participation in the 340B drug discount program. 19    A provision that violates this subsection in any contract 20between a Medicaid managed care organization or its pharmacy 21benefit manager and a 340B entity entered into, amended, or 22renewed after July 1, 2022 shall be void and unenforceable. 23    In this subsection (h-5):24    "340B entity" means a covered entity as defined in 42 25U.S.C. 256b(a)(4) authorized to participate in the 340B drug 26discount program.  HB1697 Enrolled- 44 -LRB104 03541 RTM 13564 b1    "340B pharmacy" means any pharmacy used to dispense 340B 2drugs for a covered entity, whether entity-owned or external. 3    (i) Nothing in this Section shall be construed to prohibit 4a pharmacy benefit manager from requiring the same 5reimbursement and terms and conditions for a pharmacy provider 6as for a pharmacy owned, controlled, or otherwise associated 7with the pharmacy benefit manager. 8    (j) A pharmacy benefit manager shall establish and 9implement a process for the resolution of disputes arising out 10of this Section, which shall be approved by the Department. 11    (k) The Department shall adopt rules establishing 12reasonable dispensing fees for fee-for-service payments in 13accordance with guidance or guidelines from the federal 14Centers for Medicare and Medicaid Services.15(Source: P.A. 102-558, eff. 8-20-21; 102-778, eff. 7-1-22; 16103-593, eff. 6-7-24.) 17    Section 30. The Juvenile Court Act of 1987 is amended by 18changing Section 5-515 as follows: 19    (705 ILCS 405/5-515)20    Sec. 5-515. Medical, and dental, and pharmaceutical 21treatment and care. 22    (a) At all times during temporary custody, detention or 23shelter care, the court may authorize a physician, a hospital 24or any other appropriate health care provider to provide   HB1697 Enrolled- 45 -LRB104 03541 RTM 13564 b1medical, dental or surgical procedures or pharmaceuticals if 2those procedures or pharmaceuticals are necessary to safeguard 3the minor's life or health. If the minor is covered under an 4existing medical or dental plan, the county shall be 5reimbursed for the expenses incurred for such services as if 6the minor were not held in temporary custody, detention, or 7shelter care.8    (b) If a provider of temporary custody, detention, or 9shelter care has a contract with a pharmacy benefit manager or 10a contract with an insurance company, health maintenance 11organization, limited health service organization, 12administrative services organization, or any other managed 13care organization or health insurance issuer where a pharmacy 14benefit manager administers the provider's coverage of, 15payment for, or formulary design for drugs necessary to 16safeguard the minor's life or health, the contract with the 17pharmacy benefit manager and the pharmacy benefit manager's 18activities shall be subject to Article XXXIIB of the Illinois 19Insurance Code and the authority of the Director of Insurance 20to enforce those provisions. The provider shall have all the 21rights of a plan sponsor under those provisions. 22(Source: P.A. 90-590, eff. 1-1-99.) 23    Section 35. The Unified Code of Corrections is amended by 24changing Section 3-2-2 as follows:   HB1697 Enrolled- 46 -LRB104 03541 RTM 13564 b1    (730 ILCS 5/3-2-2)  (from Ch. 38, par. 1003-2-2)2    Sec. 3-2-2. Powers and duties of the Department. 3    (1) In addition to the powers, duties, and 4responsibilities which are otherwise provided by law, the 5Department shall have the following powers:6        (a) To accept persons committed to it by the courts of 7    this State for care, custody, treatment, and 8    rehabilitation, and to accept federal prisoners and 9    noncitizens over whom the Office of the Federal Detention 10    Trustee is authorized to exercise the federal detention 11    function for limited purposes and periods of time.12        (b) To develop and maintain reception and evaluation 13    units for purposes of analyzing the custody and 14    rehabilitation needs of persons committed to it and to 15    assign such persons to institutions and programs under its 16    control or transfer them to other appropriate agencies. In 17    consultation with the Department of Alcoholism and 18    Substance Abuse (now the Department of Human Services), 19    the Department of Corrections shall develop a master plan 20    for the screening and evaluation of persons committed to 21    its custody who have alcohol or drug abuse problems, and 22    for making appropriate treatment available to such 23    persons; the Department shall report to the General 24    Assembly on such plan not later than April 1, 1987. The 25    maintenance and implementation of such plan shall be 26    contingent upon the availability of funds.  HB1697 Enrolled- 47 -LRB104 03541 RTM 13564 b1        (b-1) To create and implement, on January 1, 2002, a 2    pilot program to establish the effectiveness of 3    pupillometer technology (the measurement of the pupil's 4    reaction to light) as an alternative to a urine test for 5    purposes of screening and evaluating persons committed to 6    its custody who have alcohol or drug problems. The pilot 7    program shall require the pupillometer technology to be 8    used in at least one Department of Corrections facility. 9    The Director may expand the pilot program to include an 10    additional facility or facilities as he or she deems 11    appropriate. A minimum of 4,000 tests shall be included in 12    the pilot program. The Department must report to the 13    General Assembly on the effectiveness of the program by 14    January 1, 2003.15        (b-5) To develop, in consultation with the Illinois 16    State Police, a program for tracking and evaluating each 17    inmate from commitment through release for recording his 18    or her gang affiliations, activities, or ranks.19        (c) To maintain and administer all State correctional 20    institutions and facilities under its control and to 21    establish new ones as needed. Pursuant to its power to 22    establish new institutions and facilities, the Department 23    may, with the written approval of the Governor, authorize 24    the Department of Central Management Services to enter 25    into an agreement of the type described in subsection (d) 26    of Section 405-300 of the Department of Central Management   HB1697 Enrolled- 48 -LRB104 03541 RTM 13564 b1    Services Law. The Department shall designate those 2    institutions which shall constitute the State Penitentiary 3    System. The Department of Juvenile Justice shall maintain 4    and administer all State youth centers pursuant to 5    subsection (d) of Section 3-2.5-20. 6        Pursuant to its power to establish new institutions 7    and facilities, the Department may authorize the 8    Department of Central Management Services to accept bids 9    from counties and municipalities for the construction, 10    remodeling, or conversion of a structure to be leased to 11    the Department of Corrections for the purposes of its 12    serving as a correctional institution or facility. Such 13    construction, remodeling, or conversion may be financed 14    with revenue bonds issued pursuant to the Industrial 15    Building Revenue Bond Act by the municipality or county. 16    The lease specified in a bid shall be for a term of not 17    less than the time needed to retire any revenue bonds used 18    to finance the project, but not to exceed 40 years. The 19    lease may grant to the State the option to purchase the 20    structure outright.21        Upon receipt of the bids, the Department may certify 22    one or more of the bids and shall submit any such bids to 23    the General Assembly for approval. Upon approval of a bid 24    by a constitutional majority of both houses of the General 25    Assembly, pursuant to joint resolution, the Department of 26    Central Management Services may enter into an agreement   HB1697 Enrolled- 49 -LRB104 03541 RTM 13564 b1    with the county or municipality pursuant to such bid.2        (c-5) To build and maintain regional juvenile 3    detention centers and to charge a per diem to the counties 4    as established by the Department to defray the costs of 5    housing each minor in a center. In this subsection (c-5), 6    "juvenile detention center" means a facility to house 7    minors during pendency of trial who have been transferred 8    from proceedings under the Juvenile Court Act of 1987 to 9    prosecutions under the criminal laws of this State in 10    accordance with Section 5-805 of the Juvenile Court Act of 11    1987, whether the transfer was by operation of law or 12    permissive under that Section. The Department shall 13    designate the counties to be served by each regional 14    juvenile detention center.15        (d) To develop and maintain programs of control, 16    rehabilitation, and employment of committed persons within 17    its institutions.18        (d-5) To provide a pre-release job preparation program 19    for inmates at Illinois adult correctional centers. 20        (d-10) To provide educational and visitation 21    opportunities to committed persons within its institutions 22    through temporary access to content-controlled tablets 23    that may be provided as a privilege to committed persons 24    to induce or reward compliance. 25        (e) To establish a system of supervision and guidance 26    of committed persons in the community.  HB1697 Enrolled- 50 -LRB104 03541 RTM 13564 b1        (f) To establish in cooperation with the Department of 2    Transportation to supply a sufficient number of prisoners 3    for use by the Department of Transportation to clean up 4    the trash and garbage along State, county, township, or 5    municipal highways as designated by the Department of 6    Transportation. The Department of Corrections, at the 7    request of the Department of Transportation, shall furnish 8    such prisoners at least annually for a period to be agreed 9    upon between the Director of Corrections and the Secretary 10    of Transportation. The prisoners used on this program 11    shall be selected by the Director of Corrections on 12    whatever basis he deems proper in consideration of their 13    term, behavior and earned eligibility to participate in 14    such program - where they will be outside of the prison 15    facility but still in the custody of the Department of 16    Corrections. Prisoners convicted of first degree murder, 17    or a Class X felony, or armed violence, or aggravated 18    kidnapping, or criminal sexual assault, aggravated 19    criminal sexual abuse or a subsequent conviction for 20    criminal sexual abuse, or forcible detention, or arson, or 21    a prisoner adjudged a Habitual Criminal shall not be 22    eligible for selection to participate in such program. The 23    prisoners shall remain as prisoners in the custody of the 24    Department of Corrections and such Department shall 25    furnish whatever security is necessary. The Department of 26    Transportation shall furnish trucks and equipment for the   HB1697 Enrolled- 51 -LRB104 03541 RTM 13564 b1    highway cleanup program and personnel to supervise and 2    direct the program. Neither the Department of Corrections 3    nor the Department of Transportation shall replace any 4    regular employee with a prisoner.5        (g) To maintain records of persons committed to it and 6    to establish programs of research, statistics, and 7    planning.8        (h) To investigate the grievances of any person 9    committed to the Department and to inquire into any 10    alleged misconduct by employees or committed persons; and 11    for these purposes it may issue subpoenas and compel the 12    attendance of witnesses and the production of writings and 13    papers, and may examine under oath any witnesses who may 14    appear before it; to also investigate alleged violations 15    of a parolee's or releasee's conditions of parole or 16    release; and for this purpose it may issue subpoenas and 17    compel the attendance of witnesses and the production of 18    documents only if there is reason to believe that such 19    procedures would provide evidence that such violations 20    have occurred.21        If any person fails to obey a subpoena issued under 22    this subsection, the Director may apply to any circuit 23    court to secure compliance with the subpoena. The failure 24    to comply with the order of the court issued in response 25    thereto shall be punishable as contempt of court.26        (i) To appoint and remove the chief administrative   HB1697 Enrolled- 52 -LRB104 03541 RTM 13564 b1    officers, and administer programs of training and 2    development of personnel of the Department. Personnel 3    assigned by the Department to be responsible for the 4    custody and control of committed persons or to investigate 5    the alleged misconduct of committed persons or employees 6    or alleged violations of a parolee's or releasee's 7    conditions of parole shall be conservators of the peace 8    for those purposes, and shall have the full power of peace 9    officers outside of the facilities of the Department in 10    the protection, arrest, retaking, and reconfining of 11    committed persons or where the exercise of such power is 12    necessary to the investigation of such misconduct or 13    violations. This subsection shall not apply to persons 14    committed to the Department of Juvenile Justice under the 15    Juvenile Court Act of 1987 on aftercare release.16        (j) To cooperate with other departments and agencies 17    and with local communities for the development of 18    standards and programs for better correctional services in 19    this State.20        (k) To administer all moneys and properties of the 21    Department.22        (l) To report annually to the Governor on the 23    committed persons, institutions, and programs of the 24    Department.25        (l-5) (Blank).26        (m) To make all rules and regulations and exercise all   HB1697 Enrolled- 53 -LRB104 03541 RTM 13564 b1    powers and duties vested by law in the Department.2        (n) To establish rules and regulations for 3    administering a system of sentence credits, established in 4    accordance with Section 3-6-3, subject to review by the 5    Prisoner Review Board.6        (o) To administer the distribution of funds from the 7    State Treasury to reimburse counties where State penal 8    institutions are located for the payment of assistant 9    state's attorneys' salaries under Section 4-2001 of the 10    Counties Code.11        (p) To exchange information with the Department of 12    Human Services and the Department of Healthcare and Family 13    Services for the purpose of verifying living arrangements 14    and for other purposes directly connected with the 15    administration of this Code and the Illinois Public Aid 16    Code.17        (q) To establish a diversion program.18        The program shall provide a structured environment for 19    selected technical parole or mandatory supervised release 20    violators and committed persons who have violated the 21    rules governing their conduct while in work release. This 22    program shall not apply to those persons who have 23    committed a new offense while serving on parole or 24    mandatory supervised release or while committed to work 25    release.26        Elements of the program shall include, but shall not   HB1697 Enrolled- 54 -LRB104 03541 RTM 13564 b1    be limited to, the following:2            (1) The staff of a diversion facility shall 3        provide supervision in accordance with required 4        objectives set by the facility.5            (2) Participants shall be required to maintain 6        employment.7            (3) Each participant shall pay for room and board 8        at the facility on a sliding-scale basis according to 9        the participant's income.10            (4) Each participant shall:11                (A) provide restitution to victims in 12            accordance with any court order;13                (B) provide financial support to his 14            dependents; and15                (C) make appropriate payments toward any other 16            court-ordered obligations.17            (5) Each participant shall complete community 18        service in addition to employment.19            (6) Participants shall take part in such 20        counseling, educational, and other programs as the 21        Department may deem appropriate.22            (7) Participants shall submit to drug and alcohol 23        screening.24            (8) The Department shall promulgate rules 25        governing the administration of the program.26        (r) To enter into intergovernmental cooperation   HB1697 Enrolled- 55 -LRB104 03541 RTM 13564 b1    agreements under which persons in the custody of the 2    Department may participate in a county impact 3    incarceration program established under Section 3-6038 or 4    3-15003.5 of the Counties Code.5        (r-5) (Blank).6        (r-10) To systematically and routinely identify with 7    respect to each streetgang active within the correctional 8    system: (1) each active gang; (2) every existing 9    inter-gang affiliation or alliance; and (3) the current 10    leaders in each gang. The Department shall promptly 11    segregate leaders from inmates who belong to their gangs 12    and allied gangs. "Segregate" means no physical contact 13    and, to the extent possible under the conditions and space 14    available at the correctional facility, prohibition of 15    visual and sound communication. For the purposes of this 16    paragraph (r-10), "leaders" means persons who:17            (i) are members of a criminal streetgang;18            (ii) with respect to other individuals within the 19        streetgang, occupy a position of organizer, 20        supervisor, or other position of management or 21        leadership; and22            (iii) are actively and personally engaged in 23        directing, ordering, authorizing, or requesting 24        commission of criminal acts by others, which are 25        punishable as a felony, in furtherance of streetgang 26        related activity both within and outside of the   HB1697 Enrolled- 56 -LRB104 03541 RTM 13564 b1        Department of Corrections.2    "Streetgang", "gang", and "streetgang related" have the 3    meanings ascribed to them in Section 10 of the Illinois 4    Streetgang Terrorism Omnibus Prevention Act.5        (s) To operate a super-maximum security institution, 6    in order to manage and supervise inmates who are 7    disruptive or dangerous and provide for the safety and 8    security of the staff and the other inmates.9        (t) To monitor any unprivileged conversation or any 10    unprivileged communication, whether in person or by mail, 11    telephone, or other means, between an inmate who, before 12    commitment to the Department, was a member of an organized 13    gang and any other person without the need to show cause or 14    satisfy any other requirement of law before beginning the 15    monitoring, except as constitutionally required. The 16    monitoring may be by video, voice, or other method of 17    recording or by any other means. As used in this 18    subdivision (1)(t), "organized gang" has the meaning 19    ascribed to it in Section 10 of the Illinois Streetgang 20    Terrorism Omnibus Prevention Act.21        As used in this subdivision (1)(t), "unprivileged 22    conversation" or "unprivileged communication" means a 23    conversation or communication that is not protected by any 24    privilege recognized by law or by decision, rule, or order 25    of the Illinois Supreme Court.26        (u) To establish a Women's and Children's Pre-release   HB1697 Enrolled- 57 -LRB104 03541 RTM 13564 b1    Community Supervision Program for the purpose of providing 2    housing and services to eligible female inmates, as 3    determined by the Department, and their newborn and young 4    children.5        (u-5) To issue an order, whenever a person committed 6    to the Department absconds or absents himself or herself, 7    without authority to do so, from any facility or program 8    to which he or she is assigned. The order shall be 9    certified by the Director, the Supervisor of the 10    Apprehension Unit, or any person duly designated by the 11    Director, with the seal of the Department affixed. The 12    order shall be directed to all sheriffs, coroners, and 13    police officers, or to any particular person named in the 14    order. Any order issued pursuant to this subdivision 15    (1)(u-5) shall be sufficient warrant for the officer or 16    person named in the order to arrest and deliver the 17    committed person to the proper correctional officials and 18    shall be executed the same as criminal process. 19        (u-6) To appoint a point of contact person who shall 20    receive suggestions, complaints, or other requests to the 21    Department from visitors to Department institutions or 22    facilities and from other members of the public.23        (v) To do all other acts necessary to carry out the 24    provisions of this Chapter.25    (2) The Department of Corrections shall by January 1, 261998, consider building and operating a correctional facility   HB1697 Enrolled- 58 -LRB104 03541 RTM 13564 b1within 100 miles of a county of over 2,000,000 inhabitants, 2especially a facility designed to house juvenile participants 3in the impact incarceration program.4    (3) When the Department lets bids for contracts for 5medical services to be provided to persons committed to 6Department facilities by a health maintenance organization, 7medical service corporation, or other health care provider, 8the bid may only be let to a health care provider that has 9obtained an irrevocable letter of credit or performance bond 10issued by a company whose bonds have an investment grade or 11higher rating by a bond rating organization.12    (3.5) If the Department has a contract with a pharmacy 13benefit manager or a contract with an insurance company, 14health maintenance organization, limited health service 15organization, administrative services organization, or any 16other managed care entity or health insurance issuer where a 17pharmacy benefit manager administers the provider's coverage 18of, payment for, or formulary design for drugs necessary to 19safeguard the minor's life or health, the contract with the 20pharmacy benefit manager and the pharmacy benefit manager's 21activities shall be subject to Article XXXIIB of the Illinois 22Insurance Code and the authority of the Director of Insurance 23to enforce those provisions. The provider shall have all the 24rights of a plan sponsor under those provisions. 25    (4) When the Department lets bids for contracts for food 26or commissary services to be provided to Department   HB1697 Enrolled- 59 -LRB104 03541 RTM 13564 b1facilities, the bid may only be let to a food or commissary 2services provider that has obtained an irrevocable letter of 3credit or performance bond issued by a company whose bonds 4have an investment grade or higher rating by a bond rating 5organization.6    (5) On and after the date 6 months after August 16, 2013 7(the effective date of Public Act 98-488), as provided in the 8Executive Order 1 (2012) Implementation Act, all of the 9powers, duties, rights, and responsibilities related to State 10healthcare purchasing under this Code that were transferred 11from the Department of Corrections to the Department of 12Healthcare and Family Services by Executive Order 3 (2005) are 13transferred back to the Department of Corrections; however, 14powers, duties, rights, and responsibilities related to State 15healthcare purchasing under this Code that were exercised by 16the Department of Corrections before the effective date of 17Executive Order 3 (2005) but that pertain to individuals 18resident in facilities operated by the Department of Juvenile 19Justice are transferred to the Department of Juvenile Justice. 20    (6) The Department of Corrections shall provide lactation 21or nursing mothers rooms for personnel of the Department. The 22rooms shall be provided in each facility of the Department 23that employs nursing mothers. Each individual lactation room 24must: 25        (i) contain doors that lock; 26        (ii) have an "Occupied" sign for each door;   HB1697 Enrolled- 60 -LRB104 03541 RTM 13564 b1        (iii) contain electrical outlets for plugging in 2    breast pumps; 3        (iv) have sufficient lighting and ventilation; 4        (v) contain comfortable chairs; 5        (vi) contain a countertop or table for all necessary 6    supplies for lactation; 7        (vii) contain a wastebasket and chemical cleaners to 8    wash one's hands and to clean the surfaces of the 9    countertop or table; 10        (viii) have a functional sink; 11        (ix) have a minimum of one refrigerator for storage of 12    the breast milk; and 13        (x) receive routine daily maintenance. 14(Source: P.A. 102-350, eff. 8-13-21; 102-535, eff. 1-1-22; 15102-538, eff. 8-20-21; 102-813, eff. 5-13-22; 102-1030, eff. 165-27-22; 103-834, eff. 1-1-25.) 17    Section 40. The County Jail Act is amended by changing 18Section 17 as follows: 19    (730 ILCS 125/17)  (from Ch. 75, par. 117)20    Sec. 17. Bedding, clothing, fuel, and medical aid; 21reimbursement for medical expenses. The Warden of the jail 22shall furnish necessary bedding, clothing, fuel, and medical 23services for all committed persons under his charge, and keep 24an accurate account of the same. When services that result in   HB1697 Enrolled- 61 -LRB104 03541 RTM 13564 b1qualified medical expenses are required by any person held in 2custody, the county, private hospital, physician or any public 3agency which provides such services shall be entitled to 4obtain reimbursement from the county for the cost of such 5services. The county board of a county may adopt an ordinance 6or resolution providing for reimbursement for the cost of 7those services at the Department of Healthcare and Family 8Services' rates for medical assistance. To the extent that 9such person is reasonably able to pay for such care, including 10reimbursement from any insurance program or from other medical 11benefit programs available to such person, he or she shall 12reimburse the county or arresting authority. If such person 13has already been determined eligible for medical assistance 14under the Illinois Public Aid Code at the time the person is 15detained, the cost of such services, to the extent such cost 16exceeds $500, shall be reimbursed by the Department of 17Healthcare and Family Services under that Code. A 18reimbursement under any public or private program authorized 19by this Section shall be paid to the county or arresting 20authority to the same extent as would have been obtained had 21the services been rendered in a non-custodial environment.22    The sheriff or his or her designee may cause an 23application for medical assistance under the Illinois Public 24Aid Code to be completed for an arrestee who is a hospital 25inpatient. If such arrestee is determined eligible, he or she 26shall receive medical assistance under the Code for hospital   HB1697 Enrolled- 62 -LRB104 03541 RTM 13564 b1inpatient services only. An arresting authority shall be 2responsible for any qualified medical expenses relating to the 3arrestee until such time as the arrestee is placed in the 4custody of the sheriff. However, the arresting authority shall 5not be so responsible if the arrest was made pursuant to a 6request by the sheriff. When medical expenses are required by 7any person held in custody, the county shall be entitled to 8obtain reimbursement from the County Jail Medical Costs Fund 9to the extent moneys are available from the Fund. To the extent 10that the person is reasonably able to pay for that care, 11including reimbursement from any insurance program or from 12other medical benefit programs available to the person, he or 13she shall reimburse the county.14    For the purposes of this Section, "arresting authority" 15means a unit of local government, other than a county, which 16employs peace officers and whose peace officers have made the 17arrest of a person. For the purposes of this Section, 18"qualified medical expenses" include medical and hospital 19services but do not include (i) expenses incurred for medical 20care or treatment provided to a person on account of a 21self-inflicted injury incurred prior to or in the course of an 22arrest, (ii) expenses incurred for medical care or treatment 23provided to a person on account of a health condition of that 24person which existed prior to the time of his or her arrest, or 25(iii) expenses for hospital inpatient services for arrestees 26enrolled for medical assistance under the Illinois Public Aid   HB1697 Enrolled- 63 -LRB104 03541 RTM 13564 b1Code.2    If a jail or a unit of local government operating the jail 3has a contract with a pharmacy benefit manager or a contract 4with an insurance company, health maintenance organization, 5limited health service organization, administrative services 6organization, or any other managed care organization or health 7insurance issuer where a pharmacy benefit manager administers 8coverage of, payment for, or formulary design for drugs 9necessary to safeguard the life or health of any person in 10custody, that contract and the pharmacy benefit manager's 11activities shall be subject to Article XXXIIB of the Illinois 12Insurance Code and the authority of the Director of Insurance 13to enforce those provisions. The jail or unit of local 14government shall have all the rights of a plan sponsor under 15those provisions. 16(Source: P.A. 103-745, eff. 1-1-25.) 17    Section 99. Effective date. This Act takes effect on 18January 1, 2026, except that this Section, Section 10, and the 19changes to Sections 513b2 and 513b3 of the Illinois Insurance 20Code take effect upon becoming law.